<SEC-DOCUMENT>0001108205-22-000022.txt : 20221109
<SEC-HEADER>0001108205-22-000022.hdr.sgml : 20221109
<ACCEPTANCE-DATETIME>20221109160207
ACCESSION NUMBER:		0001108205-22-000022
CONFORMED SUBMISSION TYPE:	8-K
PUBLIC DOCUMENT COUNT:		14
CONFORMED PERIOD OF REPORT:	20221109
ITEM INFORMATION:		Results of Operations and Financial Condition
ITEM INFORMATION:		Financial Statements and Exhibits
FILED AS OF DATE:		20221109
DATE AS OF CHANGE:		20221109

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			CURIS INC
		CENTRAL INDEX KEY:			0001108205
		STANDARD INDUSTRIAL CLASSIFICATION:	BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836]
		IRS NUMBER:				043505116
		STATE OF INCORPORATION:			DE
		FISCAL YEAR END:			1231

	FILING VALUES:
		FORM TYPE:		8-K
		SEC ACT:		1934 Act
		SEC FILE NUMBER:	000-30347
		FILM NUMBER:		221372441

	BUSINESS ADDRESS:	
		STREET 1:		128 SPRING STREET
		STREET 2:		BUILDING C, SUITE 500
		CITY:			LEXINGTON
		STATE:			MA
		ZIP:			02421
		BUSINESS PHONE:		617-503-6500

	MAIL ADDRESS:	
		STREET 1:		128 SPRING STREET
		STREET 2:		BUILDING C, SUITE 500
		CITY:			LEXINGTON
		STATE:			MA
		ZIP:			02421
</SEC-HEADER>
<DOCUMENT>
<TYPE>8-K
<SEQUENCE>1
<FILENAME>cris-20221109.htm
<DESCRIPTION>8-K
<TEXT>
<XBRL>
<?xml version="1.0" ?><!--XBRL Document Created with Wdesk from Workiva--><!--Copyright 2022 Workiva--><!--r:e81a4c21-32dd-408a-b521-7c1c9605c5b8,g:5cef627b-e60c-4f67-a388-c92bfb9e0bef,d:8e09bd81f57b4535a9763a0ff0e6781b--><html xmlns:ixt="http://www.xbrl.org/inlineXBRL/transformation/2020-02-12" xmlns:ixt-sec="http://www.sec.gov/inlineXBRL/transformation/2015-08-31" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns="http://www.w3.org/1999/xhtml" xmlns:ix="http://www.xbrl.org/2013/inlineXBRL" xmlns:xbrli="http://www.xbrl.org/2003/instance" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:dei="http://xbrl.sec.gov/dei/2022" xml:lang="en-US"><head><meta http-equiv="Content-Type" content="text/html"/>


<title>cris-20221109</title></head><body><div style="display:none"><ix:header><ix:hidden><ix:nonNumeric contextRef="i65fa79e006574b989ada023c81fde3ea_D20221109-20221109" name="dei:EntityCentralIndexKey" id="id3VybDovL2RvY3MudjEvZG9jOjhlMDliZDgxZjU3YjQ1MzVhOTc2M2EwZmYwZTY3ODFiL3NlYzo4ZTA5YmQ4MWY1N2I0NTM1YTk3NjNhMGZmMGU2NzgxYl80L2ZyYWc6NzIwZGNmYjZlOGFlNDFjM2IwZWE4YjViZGJmODU5NmIvdGFibGU6M2YyOTFiNTU2Y2UwNDUzZWJlYTkwNWI4ZmYwZTNkNzcvdGFibGVyYW5nZTozZjI5MWI1NTZjZTA0NTNlYmVhOTA1YjhmZjBlM2Q3N18wLTEtMS0xLTI4MjQ3_63fa852d-0fab-4d1a-8b29-54f994002831">0001108205</ix:nonNumeric><ix:nonNumeric contextRef="i65fa79e006574b989ada023c81fde3ea_D20221109-20221109" name="dei:AmendmentFlag" id="id3VybDovL2RvY3MudjEvZG9jOjhlMDliZDgxZjU3YjQ1MzVhOTc2M2EwZmYwZTY3ODFiL3NlYzo4ZTA5YmQ4MWY1N2I0NTM1YTk3NjNhMGZmMGU2NzgxYl80L2ZyYWc6NzIwZGNmYjZlOGFlNDFjM2IwZWE4YjViZGJmODU5NmIvdGFibGU6M2YyOTFiNTU2Y2UwNDUzZWJlYTkwNWI4ZmYwZTNkNzcvdGFibGVyYW5nZTozZjI5MWI1NTZjZTA0NTNlYmVhOTA1YjhmZjBlM2Q3N18xLTEtMS0xLTI4MjQ3_1f66e096-253e-4039-8b22-34324e3b596c">false</ix:nonNumeric></ix:hidden><ix:references xml:lang="en-US"><link:schemaRef xlink:type="simple" xlink:href="cris-20221109.xsd"></link:schemaRef></ix:references><ix:resources><xbrli:context id="i65fa79e006574b989ada023c81fde3ea_D20221109-20221109"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001108205</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:startDate>2022-11-09</xbrli:startDate><xbrli:endDate>2022-11-09</xbrli:endDate></xbrli:period></xbrli:context></ix:resources></ix:header></div><div id="i8e09bd81f57b4535a9763a0ff0e6781b_1"></div><div style="min-height:42.75pt;width:100%"><div><span><br/></span></div></div><div style="margin-top:4pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:18pt;font-weight:700;line-height:120%">UNITED STATES</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:18pt;font-weight:700;line-height:120%">SECURITIES AND EXCHANGE COMMISSION</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">Washington, D.C. 20549</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div><span><br/></span></div><div style="margin-bottom:8pt;margin-top:8pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:14pt;font-weight:400;line-height:120%">_____________________</span></div><div style="margin-top:12pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:18pt;font-weight:700;line-height:120%">FORM <ix:nonNumeric contextRef="i65fa79e006574b989ada023c81fde3ea_D20221109-20221109" name="dei:DocumentType" id="id3VybDovL2RvY3MudjEvZG9jOjhlMDliZDgxZjU3YjQ1MzVhOTc2M2EwZmYwZTY3ODFiL3NlYzo4ZTA5YmQ4MWY1N2I0NTM1YTk3NjNhMGZmMGU2NzgxYl8xL2ZyYWc6MDFiOTlmNWU2ZGNkNDYwMDk2YjNlMTkwOGI0MmQzODAvdGV4dHJlZ2lvbjowMWI5OWY1ZTZkY2Q0NjAwOTZiM2UxOTA4YjQyZDM4MF8xMDc2_efae3acd-c7c1-4977-bd0c-944dd89e1610">8-K</ix:nonNumeric></span></div><div><span><br/></span></div><div style="margin-bottom:12pt;margin-top:8pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:14pt;font-weight:400;line-height:120%">_____________________</span></div><div style="margin-bottom:12pt;margin-top:8pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">CURRENT REPORT</span></div><div style="margin-bottom:12pt;margin-top:8pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934</span></div><div style="margin-bottom:12pt;margin-top:8pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Date of Report (Date of earliest event Reported): <ix:nonNumeric contextRef="i65fa79e006574b989ada023c81fde3ea_D20221109-20221109" name="dei:DocumentPeriodEndDate" format="ixt:date-monthname-day-year-en" id="id3VybDovL2RvY3MudjEvZG9jOjhlMDliZDgxZjU3YjQ1MzVhOTc2M2EwZmYwZTY3ODFiL3NlYzo4ZTA5YmQ4MWY1N2I0NTM1YTk3NjNhMGZmMGU2NzgxYl8xL2ZyYWc6MDFiOTlmNWU2ZGNkNDYwMDk2YjNlMTkwOGI0MmQzODAvdGV4dHJlZ2lvbjowMWI5OWY1ZTZkY2Q0NjAwOTZiM2UxOTA4YjQyZDM4MF8xMDk5NTExNjI4ODYw_6a5dddfa-134d-4817-a35d-27db4fd9b9f5">November&#160;9, 2022</ix:nonNumeric></span></div><div style="margin-bottom:12pt;margin-top:8pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:24pt;font-weight:700;line-height:120%"><ix:nonNumeric contextRef="i65fa79e006574b989ada023c81fde3ea_D20221109-20221109" name="dei:EntityRegistrantName" id="id3VybDovL2RvY3MudjEvZG9jOjhlMDliZDgxZjU3YjQ1MzVhOTc2M2EwZmYwZTY3ODFiL3NlYzo4ZTA5YmQ4MWY1N2I0NTM1YTk3NjNhMGZmMGU2NzgxYl8xL2ZyYWc6MDFiOTlmNWU2ZGNkNDYwMDk2YjNlMTkwOGI0MmQzODAvdGV4dHJlZ2lvbjowMWI5OWY1ZTZkY2Q0NjAwOTZiM2UxOTA4YjQyZDM4MF8xMDcy_5d493a22-5631-4ff1-a14f-b0f510529b05">Curis, Inc.</ix:nonNumeric></span></div><div style="margin-bottom:12pt;margin-top:8pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(Exact Name of Registrant as Specified in Charter)</span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.707%"><tr><td style="width:1.0%"></td><td style="width:31.744%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:33.064%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:31.892%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonNumeric contextRef="i65fa79e006574b989ada023c81fde3ea_D20221109-20221109" name="dei:EntityIncorporationStateCountryCode" format="ixt-sec:stateprovnameen" id="id3VybDovL2RvY3MudjEvZG9jOjhlMDliZDgxZjU3YjQ1MzVhOTc2M2EwZmYwZTY3ODFiL3NlYzo4ZTA5YmQ4MWY1N2I0NTM1YTk3NjNhMGZmMGU2NzgxYl8xL2ZyYWc6MDFiOTlmNWU2ZGNkNDYwMDk2YjNlMTkwOGI0MmQzODAvdGFibGU6M2VhNmZhYWU3NDdiNDAyOTk1ODBjOWY4OTY3NGExZDQvdGFibGVyYW5nZTozZWE2ZmFhZTc0N2I0MDI5OTU4MGM5Zjg5Njc0YTFkNF8wLTAtMS0xLTI4MjQ3_1c1f076c-8435-4c3f-a086-d18d61a4198b">Delaware</ix:nonNumeric></span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonNumeric contextRef="i65fa79e006574b989ada023c81fde3ea_D20221109-20221109" name="dei:EntityFileNumber" id="id3VybDovL2RvY3MudjEvZG9jOjhlMDliZDgxZjU3YjQ1MzVhOTc2M2EwZmYwZTY3ODFiL3NlYzo4ZTA5YmQ4MWY1N2I0NTM1YTk3NjNhMGZmMGU2NzgxYl8xL2ZyYWc6MDFiOTlmNWU2ZGNkNDYwMDk2YjNlMTkwOGI0MmQzODAvdGFibGU6M2VhNmZhYWU3NDdiNDAyOTk1ODBjOWY4OTY3NGExZDQvdGFibGVyYW5nZTozZWE2ZmFhZTc0N2I0MDI5OTU4MGM5Zjg5Njc0YTFkNF8wLTEtMS0xLTI4MjQ3_63685aa4-daf9-4c86-a89d-ea81f1c9b7a1">000-30347</ix:nonNumeric></span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonNumeric contextRef="i65fa79e006574b989ada023c81fde3ea_D20221109-20221109" name="dei:EntityTaxIdentificationNumber" id="id3VybDovL2RvY3MudjEvZG9jOjhlMDliZDgxZjU3YjQ1MzVhOTc2M2EwZmYwZTY3ODFiL3NlYzo4ZTA5YmQ4MWY1N2I0NTM1YTk3NjNhMGZmMGU2NzgxYl8xL2ZyYWc6MDFiOTlmNWU2ZGNkNDYwMDk2YjNlMTkwOGI0MmQzODAvdGFibGU6M2VhNmZhYWU3NDdiNDAyOTk1ODBjOWY4OTY3NGExZDQvdGFibGVyYW5nZTozZWE2ZmFhZTc0N2I0MDI5OTU4MGM5Zjg5Njc0YTFkNF8wLTItMS0xLTI4MjQ3_dfbd240d-6c2f-44e0-8cfa-f6d2e2c24424">04-3505116</ix:nonNumeric></span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(State or Other Jurisdiction of Incorporation)</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(Commission File Number)</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(I.R.S. Employer Identification Number)</span></td></tr></table></div><div style="margin-bottom:8pt;margin-top:8pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"></td><td style="width:98.900%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonNumeric contextRef="i65fa79e006574b989ada023c81fde3ea_D20221109-20221109" name="dei:EntityAddressAddressLine1" id="id3VybDovL2RvY3MudjEvZG9jOjhlMDliZDgxZjU3YjQ1MzVhOTc2M2EwZmYwZTY3ODFiL3NlYzo4ZTA5YmQ4MWY1N2I0NTM1YTk3NjNhMGZmMGU2NzgxYl8xL2ZyYWc6MDFiOTlmNWU2ZGNkNDYwMDk2YjNlMTkwOGI0MmQzODAvdGFibGU6YjI0MDY1MWUwNTc3NGQyY2EzZjNjZDc3NGMzMTRjMjUvdGFibGVyYW5nZTpiMjQwNjUxZTA1Nzc0ZDJjYTNmM2NkNzc0YzMxNGMyNV8wLTAtMS0xLTI4MjQ3L3RleHRyZWdpb246MjA4NjU1NDQ2ODljNGI5M2FjZmFhN2Y2MGZkNGY4ZDVfNA_8e3467c3-471a-4331-b411-501e1f406f8c">128 Spring Street</ix:nonNumeric>, <ix:nonNumeric contextRef="i65fa79e006574b989ada023c81fde3ea_D20221109-20221109" name="dei:EntityAddressAddressLine2" id="id3VybDovL2RvY3MudjEvZG9jOjhlMDliZDgxZjU3YjQ1MzVhOTc2M2EwZmYwZTY3ODFiL3NlYzo4ZTA5YmQ4MWY1N2I0NTM1YTk3NjNhMGZmMGU2NzgxYl8xL2ZyYWc6MDFiOTlmNWU2ZGNkNDYwMDk2YjNlMTkwOGI0MmQzODAvdGFibGU6YjI0MDY1MWUwNTc3NGQyY2EzZjNjZDc3NGMzMTRjMjUvdGFibGVyYW5nZTpiMjQwNjUxZTA1Nzc0ZDJjYTNmM2NkNzc0YzMxNGMyNV8wLTAtMS0xLTI4MjQ3L3RleHRyZWdpb246MjA4NjU1NDQ2ODljNGI5M2FjZmFhN2Y2MGZkNGY4ZDVfOA_d8b7f88a-d859-444e-b143-d6e067d1d6a8">Building C - Suite 500</ix:nonNumeric>, <ix:nonNumeric contextRef="i65fa79e006574b989ada023c81fde3ea_D20221109-20221109" name="dei:EntityAddressCityOrTown" id="id3VybDovL2RvY3MudjEvZG9jOjhlMDliZDgxZjU3YjQ1MzVhOTc2M2EwZmYwZTY3ODFiL3NlYzo4ZTA5YmQ4MWY1N2I0NTM1YTk3NjNhMGZmMGU2NzgxYl8xL2ZyYWc6MDFiOTlmNWU2ZGNkNDYwMDk2YjNlMTkwOGI0MmQzODAvdGFibGU6YjI0MDY1MWUwNTc3NGQyY2EzZjNjZDc3NGMzMTRjMjUvdGFibGVyYW5nZTpiMjQwNjUxZTA1Nzc0ZDJjYTNmM2NkNzc0YzMxNGMyNV8wLTAtMS0xLTI4MjQ3L3RleHRyZWdpb246MjA4NjU1NDQ2ODljNGI5M2FjZmFhN2Y2MGZkNGY4ZDVfMTI_c92e8b7f-ccd7-47d5-90ec-b949e4deceef">Lexington</ix:nonNumeric>, <ix:nonNumeric contextRef="i65fa79e006574b989ada023c81fde3ea_D20221109-20221109" name="dei:EntityAddressStateOrProvince" id="id3VybDovL2RvY3MudjEvZG9jOjhlMDliZDgxZjU3YjQ1MzVhOTc2M2EwZmYwZTY3ODFiL3NlYzo4ZTA5YmQ4MWY1N2I0NTM1YTk3NjNhMGZmMGU2NzgxYl8xL2ZyYWc6MDFiOTlmNWU2ZGNkNDYwMDk2YjNlMTkwOGI0MmQzODAvdGFibGU6YjI0MDY1MWUwNTc3NGQyY2EzZjNjZDc3NGMzMTRjMjUvdGFibGVyYW5nZTpiMjQwNjUxZTA1Nzc0ZDJjYTNmM2NkNzc0YzMxNGMyNV8wLTAtMS0xLTI4MjQ3L3RleHRyZWdpb246MjA4NjU1NDQ2ODljNGI5M2FjZmFhN2Y2MGZkNGY4ZDVfMTY_641ac630-f1f3-440e-830a-da66247d561a">MA</ix:nonNumeric> <ix:nonNumeric contextRef="i65fa79e006574b989ada023c81fde3ea_D20221109-20221109" name="dei:EntityAddressPostalZipCode" id="id3VybDovL2RvY3MudjEvZG9jOjhlMDliZDgxZjU3YjQ1MzVhOTc2M2EwZmYwZTY3ODFiL3NlYzo4ZTA5YmQ4MWY1N2I0NTM1YTk3NjNhMGZmMGU2NzgxYl8xL2ZyYWc6MDFiOTlmNWU2ZGNkNDYwMDk2YjNlMTkwOGI0MmQzODAvdGFibGU6YjI0MDY1MWUwNTc3NGQyY2EzZjNjZDc3NGMzMTRjMjUvdGFibGVyYW5nZTpiMjQwNjUxZTA1Nzc0ZDJjYTNmM2NkNzc0YzMxNGMyNV8wLTAtMS0xLTI4MjQ3L3RleHRyZWdpb246MjA4NjU1NDQ2ODljNGI5M2FjZmFhN2Y2MGZkNGY4ZDVfMTk_f7cad213-2f6c-48d5-9284-e9d27082f25a">02421</ix:nonNumeric></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(Address of Principal Executive Offices) (Zip Code)</span></td></tr></table></div><div style="margin-top:3pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"><ix:nonNumeric contextRef="i65fa79e006574b989ada023c81fde3ea_D20221109-20221109" name="dei:CityAreaCode" id="id3VybDovL2RvY3MudjEvZG9jOjhlMDliZDgxZjU3YjQ1MzVhOTc2M2EwZmYwZTY3ODFiL3NlYzo4ZTA5YmQ4MWY1N2I0NTM1YTk3NjNhMGZmMGU2NzgxYl8xL2ZyYWc6MDFiOTlmNWU2ZGNkNDYwMDk2YjNlMTkwOGI0MmQzODAvdGV4dHJlZ2lvbjowMWI5OWY1ZTZkY2Q0NjAwOTZiM2UxOTA4YjQyZDM4MF8xMDcz_5a071340-91d4-477f-bef7-b07e6ea8364a">(617)</ix:nonNumeric> <ix:nonNumeric contextRef="i65fa79e006574b989ada023c81fde3ea_D20221109-20221109" name="dei:LocalPhoneNumber" id="id3VybDovL2RvY3MudjEvZG9jOjhlMDliZDgxZjU3YjQ1MzVhOTc2M2EwZmYwZTY3ODFiL3NlYzo4ZTA5YmQ4MWY1N2I0NTM1YTk3NjNhMGZmMGU2NzgxYl8xL2ZyYWc6MDFiOTlmNWU2ZGNkNDYwMDk2YjNlMTkwOGI0MmQzODAvdGV4dHJlZ2lvbjowMWI5OWY1ZTZkY2Q0NjAwOTZiM2UxOTA4YjQyZDM4MF8xMDc0_7949a085-fee7-4365-9d9b-78dddaa55abf">503-6500</ix:nonNumeric></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(Registrant's telephone number, including area code)</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Not Applicable</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(Former name or former address, if changed since last report)</span></div><div style="margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:0.1%"></td><td style="width:2.581%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:6.074%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:88.945%"></td><td style="width:0.1%"></td></tr><tr><td colspan="9" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="i65fa79e006574b989ada023c81fde3ea_D20221109-20221109" name="dei:WrittenCommunications" format="ixt-sec:boolballotbox" id="id3VybDovL2RvY3MudjEvZG9jOjhlMDliZDgxZjU3YjQ1MzVhOTc2M2EwZmYwZTY3ODFiL3NlYzo4ZTA5YmQ4MWY1N2I0NTM1YTk3NjNhMGZmMGU2NzgxYl8xL2ZyYWc6MDFiOTlmNWU2ZGNkNDYwMDk2YjNlMTkwOGI0MmQzODAvdGFibGU6NzlhOWZhNjU2ZGEzNGE0ODk5NDFjZGYzYzI5OWRkZDEvdGFibGVyYW5nZTo3OWE5ZmE2NTZkYTM0YTQ4OTk0MWNkZjNjMjk5ZGRkMV8xLTEtMS0xLTI4MjQ3_6d238c4d-997a-48cf-bbc7-9628f04deca7">&#9744;</ix:nonNumeric></span></td><td colspan="3" style="padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="i65fa79e006574b989ada023c81fde3ea_D20221109-20221109" name="dei:SolicitingMaterial" format="ixt-sec:boolballotbox" id="id3VybDovL2RvY3MudjEvZG9jOjhlMDliZDgxZjU3YjQ1MzVhOTc2M2EwZmYwZTY3ODFiL3NlYzo4ZTA5YmQ4MWY1N2I0NTM1YTk3NjNhMGZmMGU2NzgxYl8xL2ZyYWc6MDFiOTlmNWU2ZGNkNDYwMDk2YjNlMTkwOGI0MmQzODAvdGFibGU6NzlhOWZhNjU2ZGEzNGE0ODk5NDFjZGYzYzI5OWRkZDEvdGFibGVyYW5nZTo3OWE5ZmE2NTZkYTM0YTQ4OTk0MWNkZjNjMjk5ZGRkMV8yLTEtMS0xLTI4MjQ3_9eecdb22-082a-4fbc-8854-b47abf8fc26c">&#9744;</ix:nonNumeric></span></td><td colspan="3" style="padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="i65fa79e006574b989ada023c81fde3ea_D20221109-20221109" name="dei:PreCommencementTenderOffer" format="ixt-sec:boolballotbox" id="id3VybDovL2RvY3MudjEvZG9jOjhlMDliZDgxZjU3YjQ1MzVhOTc2M2EwZmYwZTY3ODFiL3NlYzo4ZTA5YmQ4MWY1N2I0NTM1YTk3NjNhMGZmMGU2NzgxYl8xL2ZyYWc6MDFiOTlmNWU2ZGNkNDYwMDk2YjNlMTkwOGI0MmQzODAvdGFibGU6NzlhOWZhNjU2ZGEzNGE0ODk5NDFjZGYzYzI5OWRkZDEvdGFibGVyYW5nZTo3OWE5ZmE2NTZkYTM0YTQ4OTk0MWNkZjNjMjk5ZGRkMV8zLTEtMS0xLTI4MjQ3_aa58cf30-96f7-4c13-8cce-ed0238302268">&#9744;</ix:nonNumeric></span></td><td colspan="3" style="padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="i65fa79e006574b989ada023c81fde3ea_D20221109-20221109" name="dei:PreCommencementIssuerTenderOffer" format="ixt-sec:boolballotbox" id="id3VybDovL2RvY3MudjEvZG9jOjhlMDliZDgxZjU3YjQ1MzVhOTc2M2EwZmYwZTY3ODFiL3NlYzo4ZTA5YmQ4MWY1N2I0NTM1YTk3NjNhMGZmMGU2NzgxYl8xL2ZyYWc6MDFiOTlmNWU2ZGNkNDYwMDk2YjNlMTkwOGI0MmQzODAvdGFibGU6NzlhOWZhNjU2ZGEzNGE0ODk5NDFjZGYzYzI5OWRkZDEvdGFibGVyYW5nZTo3OWE5ZmE2NTZkYTM0YTQ4OTk0MWNkZjNjMjk5ZGRkMV80LTEtMS0xLTI4MjQ3_289bc854-2251-481d-bedc-ba1913770259">&#9744;</ix:nonNumeric></span></td><td colspan="3" style="padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))</span></td></tr></table></div><div style="text-align:center"><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Securities registered pursuant to Section 12(b) of the Act:&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;</span></div><div style="margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:97.807%"><tr><td style="width:1.0%"></td><td style="width:36.717%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.547%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:21.769%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.547%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:36.720%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Title of each class</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Trading Symbol</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Name of each exchange on which registered</span></td></tr><tr><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="i65fa79e006574b989ada023c81fde3ea_D20221109-20221109" name="dei:Security12bTitle" id="id3VybDovL2RvY3MudjEvZG9jOjhlMDliZDgxZjU3YjQ1MzVhOTc2M2EwZmYwZTY3ODFiL3NlYzo4ZTA5YmQ4MWY1N2I0NTM1YTk3NjNhMGZmMGU2NzgxYl8xL2ZyYWc6MDFiOTlmNWU2ZGNkNDYwMDk2YjNlMTkwOGI0MmQzODAvdGFibGU6ZTNmYzE3YzcyM2Y1NDNiZmI5YjY1OTBiYWZhZjcyODQvdGFibGVyYW5nZTplM2ZjMTdjNzIzZjU0M2JmYjliNjU5MGJhZmFmNzI4NF8xLTAtMS0xLTI4MjQ3_0531256e-8633-45b1-b673-4e8ef46ff48c">Common Stock, Par Value $0.01 per share</ix:nonNumeric></span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="i65fa79e006574b989ada023c81fde3ea_D20221109-20221109" name="dei:TradingSymbol" id="id3VybDovL2RvY3MudjEvZG9jOjhlMDliZDgxZjU3YjQ1MzVhOTc2M2EwZmYwZTY3ODFiL3NlYzo4ZTA5YmQ4MWY1N2I0NTM1YTk3NjNhMGZmMGU2NzgxYl8xL2ZyYWc6MDFiOTlmNWU2ZGNkNDYwMDk2YjNlMTkwOGI0MmQzODAvdGFibGU6ZTNmYzE3YzcyM2Y1NDNiZmI5YjY1OTBiYWZhZjcyODQvdGFibGVyYW5nZTplM2ZjMTdjNzIzZjU0M2JmYjliNjU5MGJhZmFmNzI4NF8xLTItMS0xLTI4MjQ3_b913cec2-78d7-4bf9-88ab-391b76197fc7">CRIS</ix:nonNumeric></span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="i65fa79e006574b989ada023c81fde3ea_D20221109-20221109" name="dei:SecurityExchangeName" format="ixt-sec:exchnameen" id="id3VybDovL2RvY3MudjEvZG9jOjhlMDliZDgxZjU3YjQ1MzVhOTc2M2EwZmYwZTY3ODFiL3NlYzo4ZTA5YmQ4MWY1N2I0NTM1YTk3NjNhMGZmMGU2NzgxYl8xL2ZyYWc6MDFiOTlmNWU2ZGNkNDYwMDk2YjNlMTkwOGI0MmQzODAvdGFibGU6ZTNmYzE3YzcyM2Y1NDNiZmI5YjY1OTBiYWZhZjcyODQvdGFibGVyYW5nZTplM2ZjMTdjNzIzZjU0M2JmYjliNjU5MGJhZmFmNzI4NF8xLTQtMS0xLTI4MjQ3_7101adf3-d323-4cf7-83a2-eff2d58ef90a">Nasdaq Global Market</ix:nonNumeric></span></td></tr></table></div><div style="text-align:center"><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (&#167;230.405 of this chapter) or Rule&#160;12b-2&#160;of the Securities Exchange Act of 1934&#160;(&#167;240.12b-2&#160;of this chapter).</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;Emerging growth company&#160;&#160;</span><span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonNumeric contextRef="i65fa79e006574b989ada023c81fde3ea_D20221109-20221109" name="dei:EntityEmergingGrowthCompany" format="ixt-sec:boolballotbox" id="id3VybDovL2RvY3MudjEvZG9jOjhlMDliZDgxZjU3YjQ1MzVhOTc2M2EwZmYwZTY3ODFiL3NlYzo4ZTA5YmQ4MWY1N2I0NTM1YTk3NjNhMGZmMGU2NzgxYl8xL2ZyYWc6MDFiOTlmNWU2ZGNkNDYwMDk2YjNlMTkwOGI0MmQzODAvdGV4dHJlZ2lvbjowMWI5OWY1ZTZkY2Q0NjAwOTZiM2UxOTA4YjQyZDM4MF8xMDc1_0ab78761-6ade-4522-b6a3-5bc535d3a732">&#9744;</ix:nonNumeric></span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span><br/></span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span><br/></span></div></div><div style="margin-top:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. </span><span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#9744;</span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span><br/></span></div></div></div><div id="i8e09bd81f57b4535a9763a0ff0e6781b_7"></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span><br/></span></div></div><div style="margin-bottom:12pt;margin-top:8pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Item 2.02. Results of Operations and Financial Condition.</span></div><div style="margin-bottom:8pt;margin-top:8pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On November&#160;9, 2022, Curis, Inc. announced its financial results for the three- and nine-month periods ended September 30, 2022. The full text of the press release issued in connection with the announcement is furnished as Exhibit 99.1 to this Current Report on Form 8-K.</span></div><div style="margin-bottom:8pt;margin-top:8pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The information in this Current Report on Form 8-K and the Exhibit attached hereto shall not be deemed "filed" for purposes of Section 18 of the Securities Exchange Act of 1934 (the "Exchange Act") or otherwise subject to the liabilities of that section, nor shall it be deemed incorporated by reference in any filing under the Securities Act of 1933 or the Exchange Act, except as expressly set forth by specific reference in such a filing.</span></div><div id="i8e09bd81f57b4535a9763a0ff0e6781b_106"></div><div style="-sec-extract:summary;margin-top:8pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Item 9.01. Financial Statements and Exhibits.</span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.707%"><tr><td style="width:1.0%"></td><td style="width:18.401%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:4.765%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:73.534%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline">Exhibit Number</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline">Description</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">99.1</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="a3q22earningspressrelease.htm">Press Release dated November 9, 2022</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">104</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cover Page Interactive Data File (embedded within the InLine XBRL document)</span></td></tr></table></div><div><span><br/></span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span><br/></span></div></div></div><div id="i8e09bd81f57b4535a9763a0ff0e6781b_10"></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span><br/></span></div></div><div style="margin-bottom:8pt;margin-top:8pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">SIGNATURE</span></div><div style="margin-bottom:12pt;margin-top:8pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.</span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:5.186%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:38.227%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:3.432%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:48.755%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="6" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Curis, Inc.</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Date:</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">November 9, 2022</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">By:&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">/</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">S</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">/&#160;&#160;&#160;&#160;J</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">AMES</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> E. D</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">ENTZER&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;</span></div></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">James E. Dentzer</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">President and Chief Executive Officer</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"></td></tr></table></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span><br/></span></div></div></div></body></html>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-99.1
<SEQUENCE>2
<FILENAME>a3q22earningspressrelease.htm
<DESCRIPTION>EX-99.1
<TEXT>
<!DOCTYPE html PUBLIC "-//W3C//DTD HTML 4.01 Transitional//EN" "http://www.w3.org/TR/html4/loose.dtd"><html><head>
<!-- Document created using Wdesk -->
<!-- Copyright 2022 Workiva -->
<title>Document</title></head><body><div id="i3d54645161e248ceb9e490a4c0eb674e_1"></div><div style="min-height:72pt;width:100%"><div style="text-align:right"><font><br></font></div></div><div style="text-align:right"><img alt="image_0a.jpg" src="image_0a.jpg" style="height:60px;margin-bottom:5pt;vertical-align:text-bottom;width:116px"></div><div><font><br></font></div><div><font style="color:#000000;font-family:'Arial',sans-serif;font-size:16pt;font-weight:700;line-height:139%">PRESS RELEASE</font></div><div><font><br></font></div><div style="text-align:center"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:16pt;font-weight:400;line-height:139%">Curis Provides Third Quarter 2022 Business Update</font></div><div><font><br></font></div><div style="text-align:center"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:112%">Data from additional patients in the TakeAim Leukemia trial of emavusertib to be presented during ASH 2022</font></div><div><font><br></font></div><div style="text-align:center"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:112%">Curis focuses its resources to drive the development of emavusertib </font></div><div><font><br></font></div><div style="text-align:center;text-indent:18pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Cash runway extended into 2025</font></div><div><font><br></font></div><div style="text-align:center"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Management to host conference call today at 4&#58;30 p.m. ET</font></div><div style="text-align:center"><font><br></font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">LEXINGTON, Mass., November 9, 2022 &#47;PRNewswire&#47; -- Curis, Inc. (NASDAQ&#58; CRIS), a biotechnology company focused on the development of innovative therapeutics for the treatment of cancer, today reported its business update and financial results for the third quarter ended September 30, 2022.</font></div><div><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company plans to release updated data from its TakeAim Leukemia Phase 1&#47;2 trial of emavusertib in relapsed or refractory (R&#47;R) acute myeloid leukemia (AML) and high-risk myelodysplastic syndromes (hrMDS) during the upcoming 64th annual meeting of the American Society of Hematology (ASH) in New Orleans on December 10-13, 2022. The release includes data for 11 additional evaluable AML&#47;hrMDS patients treated with monotherapy (total to date 24) in targeted populations (patients with U2AF1, SF3B1 or FLT3 mutations), as well as 5 AML&#47;hrMDS patients treated with the combination of emavusertib and venetoclax.</font></div><div><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">To further advance the development of emavusertib based on these data, the Company is concentrating its resources to focus on and accelerate emavusertib. Resources will be reallocated to the emavusertib programs and resources dedicated to all other pipeline programs will be reduced. Deprioritization of other programs will enable a reduction of approximately 30% of the Company&#8217;s workforce and is expected to extend the Company&#8217;s cash runway into 2025. </font></div><div><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8220;We believe emavusertib&#8217;s potential to address an area of high unmet need in R&#47;R AML and R&#47;R hrMDS sets it apart. To that end, we are dedicating the resources of the company to prioritize the acceleration of its regulatory path,&#8221; said James Dentzer, President and Chief Executive Officer of Curis. &#8220;While we continue to believe in our entire pipeline, we recognize the unique potential of emavusertib and are fortunate that our existing cash will allow us to extend our runway into 2025 to advance its development,&#8221; continued Mr. Dentzer.</font></div><div style="text-align:justify"><font><br></font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="text-align:right"><font><br></font></div></div><div style="text-align:justify"><font><br></font></div><div id="i3d54645161e248ceb9e490a4c0eb674e_36"></div><div><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:139%">Third Quarter 2022 and Recent Operational Highlights</font></div><div><font><br></font></div><div><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:139%">Precision Oncology, Emavusertib (IRAK4 Inhibitor)</font></div><div><font><br></font></div><div style="padding-left:36pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%">&#8226;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:139%;padding-left:14.5pt">The Company announced in August that, after review of the comprehensive data packages submitted by the Company, the FDA has allowed enrollment to resume in the TakeAim Lymphoma study and </font><font style="background-color:#ffffff;color:#2b2b2b;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:139%">in the monotherapy dose finding phase (Phase 1a) of the TakeAim Leukemia study</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:139%">.</font></div><div style="padding-left:36pt"><font><br></font></div><div style="padding-left:36pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%">&#8226;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:139%;padding-left:14.5pt">Curis held the first annual IRAK4 in Cancer symposium virtually on October 7, 2022 where leaders from academia and industry gathered to present their cutting edge research on IRAK4, its biology and the role it could play as a target for therapeutic intervention.</font></div><div><font><br></font></div><div><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:139%">Upcoming Milestones</font></div><div><font><br></font></div><div style="padding-left:36pt;text-indent:-18pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">The Company plans to report monotherapy and combination data from the TakeAim Leukemia studies during ASH 2022.</font></div><div><font><br></font></div><div><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:139%">Third Quarter 2022 Financial Results</font></div><div><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:139%">For the third quarter of 2022, Curis reported a net loss of $13.3 million or $0.14 per share on both a basic and diluted basis, as compared to a net loss of $11.1 million, or $0.12 per share on both a basic and diluted basis for the same period in 2021. Curis reported a net loss of $45.3 million or $0.49 per share on both a basic and diluted basis, for the nine months ended September 30, 2022 as compared to a net loss of $31.8 million, or $0.35 per share on both a basic and diluted basis for the same period in 2021.</font></div><div><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Revenues, net for the third quarter of 2022 and 2021 were $2.8 million and $3.0 million, respectively. Revenues, net for the nine months ended September 30, 2022 were $7.3 million as compared to $7.5 million for the same period in 2021. Revenues for both periods comprise primarily royalty revenues recorded on Genentech and Roche's net sales of Erivedge&#174;.</font></div><div><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Operating expenses for the third quarter of 2022 were $15.4 million, as compared to $13.1 million for the same period in 2021. Operating expenses for the nine months ended September 30, 2022 were $50.1 million, as compared to $37.0 million for the same period in 2021, and comprised the following&#58;</font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Cost of Royalty Revenues</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">. Cost of royalty revenues, which represents amounts due to third-party university patent licensors in connection with Genentech and Roche's Erivedge net sales, were $0.1 million for the third quarter of 2022 and $0.2 million for the same period in 2021. Cost of royalty revenues for the nine months ended September 30, 2022 were $0.2 million, as compared to $0.4 million for the same period in 2021.</font></div><div><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Research and Development Expenses</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">. Research and development expenses were $10.8 million for the third quarter of 2022 as compared to $8.6 million for the same period in 2021. The increase in research and development expenses for the quarter is primarily attributable to increased personnel and consulting costs, partially offset by decreased manufacturing and clinical development costs. Research and development expenses were $34.6 million for the nine months ended September 30, 2022 as compared to $24.1 million for the same period in 2021.</font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:139%">General and Administrative Expenses.</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:139%">&#160;General and administrative expenses were $4.6 million for the third quarter of 2022, as compared to $4.3 million for the same period in 2021. The increase in general </font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="text-align:right"><font><br></font></div></div><div style="text-align:justify"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:139%">and administrative expenses was driven primarily by the timing of costs. General and administrative expenses were $15.3 million for the nine months ended September 30, 2022, as compared to $12.5 million for the same period in 2021.</font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:139%">Other Expense</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:139%">. For the third quarter of 2022 and 2021, total other expense was $0.7 million and $1.0 million, respectively.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%"> </font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:139%">Other expense primarily consisted of imputed interest expense related to future royalty payments partially offset by interest income. Other expense was $2.5 million for the nine months ended September 30, 2022, as compared to $2.3 million for the same period in 2021.</font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:139%">As of September 30, 2022, Curis's cash, cash equivalents and investments totaled $98.7 million, and the Company had approximately 96.4 million shares of common stock outstanding. Curis expects that its existing cash, cash equivalents and investments should enable it to maintain its planned operations into 2025.</font></div><div style="text-align:justify"><font><br></font></div><div><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:139%">Conference Call Information</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:139%">  <br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:139%">Curis management will host a conference call today, November 9, 2022, at 4&#58;30 p.m. ET, to discuss the business update and these financial results.</font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:139%">To access the live conference call, please dial 1-888-346-6389 from the United States or 1-412-317-5252 from other locations, shortly before 4&#58;30 p.m. ET. The conference call can also be accessed on the Curis website at in the Investors section.</font></div><div style="text-align:justify"><font><br></font></div><div><font style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:139%">About Curis, Inc.</font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:133%">Curis is a biotechnology company focused on the development of innovative therapeutics for the treatment of cancer. In 2015, Curis entered into a collaboration with Aurigene in the areas of immuno-oncology and precision oncology. As part of this collaboration, Curis has exclusive licenses to oral small molecule antagonists of immune checkpoints including the VISTA&#47;PDL1 antagonist CA-170, and the TIM3&#47;PDL1 antagonist CA-327, as well as the IRAK4 kinase inhibitor, emavusertib (CA-4948). Emavusertib is currently undergoing testing in the Phase 1&#47;2 TakeAim Lymphoma trial, in patients with hematologic malignancies, such as non-Hodgkin's lymphoma and other B cell malignancies, both as a monotherapy and in combination with BTK inhibitor ibrutinib, and the Phase 1&#47;2 TakeAim Leukemia trial in patients with acute myeloid leukemia and myelodysplastic syndrome, for which it has received Orphan Drug Designation from the U.S. Food and Drug Administration. The FDA has placed a partial clinical hold on the TakeAim Leukemia trial during which no new patients will be enrolled in the monotherapy expansion phase (Phase 2a) or the combination phase (Phase 1b) of emavusertib with azacitidine or venetoclax, and current study participants benefiting from treatment may continue to be treated with emavusertib at doses of 300mg BID or lower. In addition, Curis is engaged in a collaboration with ImmuNext for development of CI-8993, a monoclonal anti-VISTA antibody, which is currently undergoing testing in a Phase 1 trial in patients with solid tumors. Curis is also party to a collaboration with Genentech, a member of the Roche Group, under which Genentech and Roche are commercializing Erivedge&#174; for the treatment of advanced basal cell carcinoma. For more information, visit Curis's website at </font><font style="background-color:#ffffff;color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:133%;text-decoration:underline">www.curis.com</font><font style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:133%">.  </font></div><div style="text-align:justify"><font><br></font></div><div><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:139%">Cautionary Note Regarding Forward-Looking Statements&#58; </font></div><div><font><br></font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="text-align:right"><font><br></font></div></div><div style="text-align:justify"><font style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:133%">This press release contains forward-looking statements within the meaning of the U.S. Private Securities Litigation Reform Act of 1995, including, without limitation, any statements with respect to Curis's plans, strategies and objectives, </font><font style="background-color:#ffffff;color:#2b2b2b;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:133%">cash runway, </font><font style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:133%"> statements concerning product research, development, clinical trials and studies and commercialization plans, timelines, anticipated results or the therapeutic potential of drug candidates including any statements regarding the initiation, progression, expansion, use, safety, efficacy, dosage and potential benefits of emavusertib in clinical trials as a monotherapy and&#47;or as a combination therapy, </font><font style="background-color:#ffffff;color:#2b2b2b;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:133%">the progression, use and potential benefits of CI-8993, </font><font style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:133%">Curis's plans and timelines to provide preliminary, interim and&#47;or additional data from its ongoing or planned clinical trials, its ability to resume and further patient enrollment in its TakeAim Lymphoma trial and in the monotherapy dose escalation phase (Phase 1a) of the TakeAim Leukemia trial, its ability to resolve the remaining partial clinical hold on the monotherapy expansion phase (Phase 2a) and the combination therapy phase (Phase 1b) of the TakeAim Leukemia study, any statements concerning Curis's expectations regarding its interactions with the FDA, statements with respect to mutations or potential biomarkers, and statements of assumptions underlying any of the foregoing.  Forward-looking statements may contain the words &#34;believes,&#34; &#34;expects,&#34; &#34;anticipates,&#34; &#34;plans,&#34; &#34;intends,&#34; &#34;seeks,&#34; &#34;estimates,&#34; &#34;assumes,&#34; &#34;predicts,&#34; &#34;projects,&#34; &#34;targets,&#34; &#34;will,&#34; &#34;may,&#34; &#34;would,&#34; &#34;could,&#34; &#34;should,&#34; &#34;continue,&#34; &#34;potential,&#34; &#34;focus,&#34; &#34;strategy,&#34; &#34;mission,&#34; or similar expressions. These forward-looking statements are not guarantees of future performance and involve risks, uncertainties, assumptions and other important factors that may cause actual results to be materially different from those indicated by such forward-looking statements. For example, the FDA may not remove the remaining partial clinical hold on the monotherapy expansion phase (Phase 2a) and the combination therapy phase (Phase 1b) of the TakeAim Leukemia trial or may take further regulatory action with regard to such trial. Curis may experience adverse results, delays and&#47;or failures in its drug development programs and may not be able to successfully advance the development of its drug candidates in the time frames it projects, if at all. Curis's drug candidates may cause unexpected toxicities, fail to demonstrate sufficient safety and efficacy in clinical studies and&#47;or may never achieve the requisite regulatory approvals needed for commercialization. Favorable results seen in preclinical studies and early clinical trials of Curis's drug candidates may not be replicated in later trials. There can be no guarantee that the collaboration agreements with Aurigene and ImmuNext will continue for their full terms, or the CRADA with NCI, that Curis or its collaborators will each maintain the financial and other resources necessary to continue financing its portion of the research, development and commercialization costs, or that the parties will successfully discover, develop or commercialize drug candidates under the collaboration. Regulatory authorities may determine to delay or restrict Genentech's and&#47;or Roche's ability to continue to develop or commercialize Erivedge in basal cell carcinoma (BCC). Erivedge may not demonstrate sufficient or any activity to merit its further development in disease indications other than BCC. Competing drugs may be developed that are superior to Erivedge. In connection with its agreement with Oberland Capital, Curis faces risks relating to the transfer and encumbrance of certain royalty and royalty-related payments on commercial sales of Erivedge, including the risk that, in the event of a default by Curis or its wholly-owned subsidiary, Curis could lose all retained rights to future royalty and royalty-related payments, Curis could be required to repurchase such future royalty and royalty-related payments at a price that is a multiple of the payments it has received, and its ability to enter into future arrangements may be inhibited, all of which could have a material adverse effect on its business, financial condition and stock price. Curis will require substantial additional capital to fund its business. If it is not able to obtain sufficient funding, it will be forced to delay, reduce in scope or eliminate some of its research and development programs, including related clinical trials and operating expenses, potentially delaying the time to market for, or preventing the marketing of, any of its product candidates, which could adversely affect its business prospects and its ability to continue operations, and would have a negative impact on its financial condition and its ability to pursue its business strategies. Curis faces substantial competition. Curis and its collaborators face the risk of potential adverse decisions made by the FDA and other regulatory authorities, investigational review boards, and publication review </font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="text-align:right"><font><br></font></div></div><div style="text-align:justify"><font style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:133%">bodies. Curis may not obtain or maintain necessary patent protection and could become involved in expensive and time-consuming patent litigation and interference proceedings. Unstable market and economic conditions, natural disasters, public health crises, political crises and other events outside of Curis's control could significantly disrupt its operations or the operations of third parties on which Curis depends and could adversely impact Curis's operating results and its ability to raise capital. For example, the COVID-19 pandemic may result in closures of third-party facilities, impact enrollment in clinical trials or impact sales of Erivedge by Genentech and&#47;or Roche.  The extent to which the COVID-19 pandemic may impact Curis's business or operating results is uncertain. Other important factors that may cause or contribute to actual results being materially different from those indicated by forward-looking statements include the factors set forth under the captions &#34;Risk Factor Summary&#34; and &#34;Risk Factors&#34; in our most recent Form 10-K and Form 10-Q, and the factors that are discussed in other filings that we periodically make with the Securities and Exchange Commission (&#34;SEC&#34;). In addition, any forward-</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:133%">looking statements represent the views of Curis only as of today and should not be relied upon as representing Curis's views as of any subsequent date. Curis disclaims any intention or obligation to update any of the forward-looking statements after the date of this press release whether as a result of new information, future events or otherwise, except as may be required by law.</font></div><div style="text-align:justify"><font><br></font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="text-align:right"><font><br></font></div></div><div style="text-align:justify"><font><br></font></div><div style="text-align:center"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">CURIS, INC.</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS</font></div><div style="text-align:center"><font><br></font></div><div style="text-align:center"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(UNAUDITED)</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(In thousands, except share and per share data)</font></div><div style="text-align:center"><font><br></font></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:51.055%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.394%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.518%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.394%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.374%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.394%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.374%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.397%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Three Months Ended<br>September 30,</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Nine Months Ended<br>September 30,</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2022</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2021</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2022</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2021</font></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Revenues, net&#58;</font></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Royalties</font></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</font></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,843&#160;</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</font></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,058&#160;</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</font></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7,377&#160;</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</font></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7,593&#160;</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other revenue</font></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</font></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</font></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</font></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1&#160;</font></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Contra revenue, net</font></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(18)</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(19)</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(102)</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(80)</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 37pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total revenues, net</font></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,825&#160;</font></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,039&#160;</font></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7,275&#160;</font></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7,514&#160;</font></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Costs and expenses&#58;</font></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cost of royalty revenues</font></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">62&#160;</font></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">151&#160;</font></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">186&#160;</font></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">376&#160;</font></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Research and development</font></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10,813&#160;</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8,602&#160;</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">34,571&#160;</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">24,112&#160;</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">General and administrative</font></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,556&#160;</font></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,334&#160;</font></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">15,318&#160;</font></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">12,524&#160;</font></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 37pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total costs and expenses</font></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">15,431&#160;</font></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">13,087&#160;</font></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">50,075&#160;</font></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">37,012&#160;</font></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 37pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Loss from operations</font></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(12,606)</font></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(10,048)</font></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(42,800)</font></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(29,498)</font></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other expense&#58;</font></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Interest income</font></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">335&#160;</font></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">54&#160;</font></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">577&#160;</font></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">158&#160;</font></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Imputed interest expense related to the sale of future royalties</font></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,023)</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,057)</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(3,120)</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(3,366)</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 28pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other income (expense), net</font></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</font></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</font></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</font></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">890&#160;</font></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 37pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total other expense</font></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(688)</font></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,003)</font></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(2,543)</font></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(2,318)</font></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 37pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net loss</font></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</font></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(13,294)</font></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</font></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(11,051)</font></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</font></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(45,343)</font></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</font></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(31,816)</font></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net loss per common share (basic and diluted)</font></td><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</font></td><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(0.14)</font></td><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</font></td><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(0.12)</font></td><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</font></td><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(0.49)</font></td><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</font></td><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(0.35)</font></td><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Weighted average common shares (basic and diluted)</font></td><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">93,791,178&#160;</font></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">91,601,362&#160;</font></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">92,370,359&#160;</font></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">91,552,433&#160;</font></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div><font><br></font></div><div><font><br></font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="text-align:right"><font><br></font></div></div><div style="text-align:center"><font><br></font></div><div style="text-align:center"><font><br></font></div><div style="margin-bottom:5pt;text-align:center"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">CURIS, INC.</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">CONDENSED CONSOLIDATED BALANCE SHEETS</font></div><div style="text-align:center"><font><br></font></div><div style="text-align:center"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(UNAUDITED)</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(In thousands)</font></div><div style="text-align:center"><font><br></font></div><div style="margin-bottom:5pt;text-align:center"><font><br></font></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:52.425%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:1.883%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:2.684%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:19.733%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.921%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.601%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.714%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.714%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.925%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:100%">September 30, 2022</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:100%">December 31, 2021</font></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 1.02pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">ASSETS</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-bottom:1.5pt;margin-top:3.75pt;padding-left:18pt;text-indent:-18pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:101%">Cash, cash equivalents and investments</font></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 1.02pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</font></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:top"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">98,689&#160;</font></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 1.02pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</font></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:top"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">139,848&#160;</font></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 1.02pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Restricted cash</font></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="6" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:top"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">635&#160;</font></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="6" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:top"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">726&#160;</font></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 1.02pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accounts receivable</font></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="6" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:top"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,886&#160;</font></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="6" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:top"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,224&#160;</font></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 1.02pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Property and equipment, net</font></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="6" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:top"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">780&#160;</font></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="6" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:top"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">505&#160;</font></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 1.02pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Operating lease right-of-use asset</font></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="6" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:top"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,718&#160;</font></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="6" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,749&#160;</font></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 1.02pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Goodwill</font></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="6" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:top"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8,982&#160;</font></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="6" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:top"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8,982&#160;</font></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 1.02pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Prepaid expenses and other assets</font></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="6" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:top"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6,164&#160;</font></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="6" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:top"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,267&#160;</font></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.77pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total assets</font></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 1.02pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</font></td><td colspan="3" style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:top"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">122,854&#160;</font></td><td colspan="3" style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 1.02pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</font></td><td colspan="3" style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:top"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">162,301&#160;</font></td><td colspan="3" style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr style="height:15pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="9" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="9" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"></td></tr><tr><td colspan="27" style="background-color:#ffffff;padding:2px 1pt 2px 1.02pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">LIABILITIES AND STOCKHOLDERS&#8217; EQUITY</font></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 1.02pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accounts payable, accrued liabilities and other liabilities</font></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 1.02pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</font></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:top"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">12,639&#160;</font></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt 0 1.02pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 1.02pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</font></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:top"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">12,756</font></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 1.02pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Operating lease liability</font></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="6" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,201&#160;</font></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="6" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,040&#160;</font></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ccecff;padding:2px 1pt 2px 1.02pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Liability related to the sale of future royalties, net</font></td><td colspan="3" style="background-color:#ccecff;padding:0 1pt"></td><td colspan="6" style="background-color:#ccecff;border-bottom:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">50,269&#160;</font></td><td colspan="3" style="background-color:#ccecff;padding:0 1pt"></td><td colspan="3" style="background-color:#ccecff;padding:0 1pt"></td><td colspan="6" style="background-color:#ccecff;border-bottom:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">53,798&#160;</font></td><td colspan="3" style="background-color:#ccecff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.27pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total liabilities</font></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="6" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:top"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">67,109&#160;</font></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="6" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:top"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">71,594&#160;</font></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ccecff;padding:2px 1pt 2px 1.02pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total stockholders' equity</font></td><td colspan="3" style="background-color:#ccecff;padding:0 1pt"></td><td colspan="6" style="background-color:#ccecff;padding:2px 1.02pt 2px 1pt;text-align:right;vertical-align:top"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">55,745  </font></td><td colspan="3" style="background-color:#ccecff;padding:0 1pt"></td><td colspan="3" style="background-color:#ccecff;padding:0 1pt"></td><td colspan="6" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:top"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">90,707</font></td><td colspan="3" style="background-color:#ccecff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.77pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total liabilities and stockholders' equity</font></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 1.02pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</font></td><td colspan="3" style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><div style="margin-bottom:1.5pt;margin-top:2.75pt;padding-right:0.75pt;text-align:right"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:97%">122,854</font></div></td><td colspan="3" style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 1.02pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</font></td><td colspan="3" style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:top"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">162,301&#160;</font></td><td colspan="3" style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:0 1pt"></td></tr></table></div><div style="text-align:justify"><font><br></font></div><div><font><br></font></div><div><font><br></font></div><div><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:139%">For further information&#58;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:139%"> </font></div><div><font style="color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:133%;text-decoration:underline">mailto&#58;ir</font><font style="background-color:#ffffff;color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:133%;text-decoration:underline">&#64;curis.com</font></div><div><font><br></font></div><div><font><br></font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div></body></html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.SCH
<SEQUENCE>3
<FILENAME>cris-20221109.xsd
<DESCRIPTION>XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT
<TEXT>
<XBRL>
<?xml version="1.0" encoding="UTF-8"?>

<!--XBRL Document Created with Wdesk from Workiva-->
<!--Copyright 2022 Workiva-->
<!--r:e81a4c21-32dd-408a-b521-7c1c9605c5b8,g:5cef627b-e60c-4f67-a388-c92bfb9e0bef-->
<xs:schema xmlns:xs="http://www.w3.org/2001/XMLSchema" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:cris="http://www.curis.com/20221109" attributeFormDefault="unqualified" elementFormDefault="qualified" targetNamespace="http://www.curis.com/20221109">
  <xs:import namespace="http://www.w3.org/1999/xlink" schemaLocation="http://www.xbrl.org/2003/xlink-2003-12-31.xsd"/>
  <xs:import namespace="http://www.xbrl.org/2003/instance" schemaLocation="http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd"/>
  <xs:import namespace="http://www.xbrl.org/2003/linkbase" schemaLocation="http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd"/>
  <xs:import namespace="http://xbrl.sec.gov/dei/2022" schemaLocation="https://xbrl.sec.gov/dei/2022/dei-2022.xsd"/>
  <xs:annotation>
    <xs:appinfo>
      <link:linkbaseRef xmlns:xlink="http://www.w3.org/1999/xlink" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:href="cris-20221109_lab.xml" xlink:role="http://www.xbrl.org/2003/role/labelLinkbaseRef" xlink:type="simple"/>
      <link:linkbaseRef xmlns:xlink="http://www.w3.org/1999/xlink" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:href="cris-20221109_pre.xml" xlink:role="http://www.xbrl.org/2003/role/presentationLinkbaseRef" xlink:type="simple"/>
      <link:roleType id="CoverPage" roleURI="http://www.curis.com/role/CoverPage">
        <link:definition>0000001 - Document - Cover Page</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
    </xs:appinfo>
  </xs:annotation>
</xs:schema>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.LAB
<SEQUENCE>4
<FILENAME>cris-20221109_lab.xml
<DESCRIPTION>XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT
<TEXT>
<XBRL>
<?xml version="1.0" encoding="UTF-8"?>

<!--XBRL Document Created with Wdesk from Workiva-->
<!--Copyright 2022 Workiva-->
<!--r:e81a4c21-32dd-408a-b521-7c1c9605c5b8,g:5cef627b-e60c-4f67-a388-c92bfb9e0bef-->
<link:linkbase xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedPeriodStartLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedPeriodStartLabel"/>
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/netLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/net-2009-12-16.xsd#netLabel"/>
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedNetLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedNetLabel"/>
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedTerseLabel"/>
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedPeriodEndLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedPeriodEndLabel"/>
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedLabel"/>
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedTotalLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedTotalLabel"/>
  <link:labelLink xlink:role="http://www.xbrl.org/2003/role/link" xlink:type="extended">
    <link:label id="lab_dei_EntityCentralIndexKey_4591cbba-caa9-45b2-a82a-a7c1272a8f78_terseLabel_en-US" xlink:label="lab_dei_EntityCentralIndexKey" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Central Index Key</link:label>
    <link:label id="lab_dei_EntityCentralIndexKey_label_en-US" xlink:label="lab_dei_EntityCentralIndexKey" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Central Index Key</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityCentralIndexKey" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityCentralIndexKey"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityCentralIndexKey" xlink:to="lab_dei_EntityCentralIndexKey" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityAddressAddressLine2_4d45dbf1-4b46-499e-8624-725ba275b93b_terseLabel_en-US" xlink:label="lab_dei_EntityAddressAddressLine2" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Address, Address Line Two</link:label>
    <link:label id="lab_dei_EntityAddressAddressLine2_label_en-US" xlink:label="lab_dei_EntityAddressAddressLine2" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Address, Address Line Two</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressAddressLine2" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityAddressAddressLine2"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityAddressAddressLine2" xlink:to="lab_dei_EntityAddressAddressLine2" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityTaxIdentificationNumber_7ed74ace-2391-42bb-bae2-2e656ece8d07_terseLabel_en-US" xlink:label="lab_dei_EntityTaxIdentificationNumber" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Tax Identification Number</link:label>
    <link:label id="lab_dei_EntityTaxIdentificationNumber_label_en-US" xlink:label="lab_dei_EntityTaxIdentificationNumber" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Tax Identification Number</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityTaxIdentificationNumber" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityTaxIdentificationNumber"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityTaxIdentificationNumber" xlink:to="lab_dei_EntityTaxIdentificationNumber" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityAddressAddressLine1_5c67563e-280c-47b1-af22-368d60447d46_terseLabel_en-US" xlink:label="lab_dei_EntityAddressAddressLine1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Address, Address Line One</link:label>
    <link:label id="lab_dei_EntityAddressAddressLine1_label_en-US" xlink:label="lab_dei_EntityAddressAddressLine1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Address, Address Line One</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressAddressLine1" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityAddressAddressLine1"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityAddressAddressLine1" xlink:to="lab_dei_EntityAddressAddressLine1" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_TradingSymbol_e696d434-6f2d-49ad-be07-cfe928ef9e70_terseLabel_en-US" xlink:label="lab_dei_TradingSymbol" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Trading Symbol</link:label>
    <link:label id="lab_dei_TradingSymbol_label_en-US" xlink:label="lab_dei_TradingSymbol" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Trading Symbol</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_TradingSymbol" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_TradingSymbol"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_TradingSymbol" xlink:to="lab_dei_TradingSymbol" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityFileNumber_5afb929a-877b-4d94-a22d-d6782de912a2_terseLabel_en-US" xlink:label="lab_dei_EntityFileNumber" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity File Number</link:label>
    <link:label id="lab_dei_EntityFileNumber_label_en-US" xlink:label="lab_dei_EntityFileNumber" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity File Number</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityFileNumber" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityFileNumber"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityFileNumber" xlink:to="lab_dei_EntityFileNumber" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_PreCommencementIssuerTenderOffer_21a99738-c029-4eae-908c-1302ab9a8b45_terseLabel_en-US" xlink:label="lab_dei_PreCommencementIssuerTenderOffer" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Pre-commencement Issuer Tender Offer</link:label>
    <link:label id="lab_dei_PreCommencementIssuerTenderOffer_label_en-US" xlink:label="lab_dei_PreCommencementIssuerTenderOffer" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Pre-commencement Issuer Tender Offer</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_PreCommencementIssuerTenderOffer" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_PreCommencementIssuerTenderOffer"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_PreCommencementIssuerTenderOffer" xlink:to="lab_dei_PreCommencementIssuerTenderOffer" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_SolicitingMaterial_7d36f3ab-cc70-47f2-b691-5d8a1f33fe35_terseLabel_en-US" xlink:label="lab_dei_SolicitingMaterial" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Soliciting Material</link:label>
    <link:label id="lab_dei_SolicitingMaterial_label_en-US" xlink:label="lab_dei_SolicitingMaterial" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Soliciting Material</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_SolicitingMaterial" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_SolicitingMaterial"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_SolicitingMaterial" xlink:to="lab_dei_SolicitingMaterial" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityAddressCityOrTown_b943bb22-2147-47ad-ab0f-b445cf3aa049_terseLabel_en-US" xlink:label="lab_dei_EntityAddressCityOrTown" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Address, City or Town</link:label>
    <link:label id="lab_dei_EntityAddressCityOrTown_label_en-US" xlink:label="lab_dei_EntityAddressCityOrTown" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Address, City or Town</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressCityOrTown" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityAddressCityOrTown"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityAddressCityOrTown" xlink:to="lab_dei_EntityAddressCityOrTown" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityIncorporationStateCountryCode_a65ce0db-7110-46b3-bb0c-604a32c82edd_terseLabel_en-US" xlink:label="lab_dei_EntityIncorporationStateCountryCode" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Incorporation, State or Country Code</link:label>
    <link:label id="lab_dei_EntityIncorporationStateCountryCode_label_en-US" xlink:label="lab_dei_EntityIncorporationStateCountryCode" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Incorporation, State or Country Code</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityIncorporationStateCountryCode" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityIncorporationStateCountryCode"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityIncorporationStateCountryCode" xlink:to="lab_dei_EntityIncorporationStateCountryCode" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_LocalPhoneNumber_b06b456b-346b-44dd-bdb0-69bcd10fd24e_terseLabel_en-US" xlink:label="lab_dei_LocalPhoneNumber" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Local Phone Number</link:label>
    <link:label id="lab_dei_LocalPhoneNumber_label_en-US" xlink:label="lab_dei_LocalPhoneNumber" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Local Phone Number</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_LocalPhoneNumber" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_LocalPhoneNumber"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_LocalPhoneNumber" xlink:to="lab_dei_LocalPhoneNumber" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityAddressPostalZipCode_ac9418ea-ff50-48a5-83dc-d5f50e6765ea_terseLabel_en-US" xlink:label="lab_dei_EntityAddressPostalZipCode" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Address, Postal Zip Code</link:label>
    <link:label id="lab_dei_EntityAddressPostalZipCode_label_en-US" xlink:label="lab_dei_EntityAddressPostalZipCode" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Address, Postal Zip Code</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressPostalZipCode" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityAddressPostalZipCode"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityAddressPostalZipCode" xlink:to="lab_dei_EntityAddressPostalZipCode" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_WrittenCommunications_2635ab6e-0b76-4231-bd4a-aff8d30d9a17_terseLabel_en-US" xlink:label="lab_dei_WrittenCommunications" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Written Communications</link:label>
    <link:label id="lab_dei_WrittenCommunications_label_en-US" xlink:label="lab_dei_WrittenCommunications" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Written Communications</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_WrittenCommunications" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_WrittenCommunications"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_WrittenCommunications" xlink:to="lab_dei_WrittenCommunications" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_CityAreaCode_a6dbfdbb-bec3-413d-b5dd-2b27e3a84780_terseLabel_en-US" xlink:label="lab_dei_CityAreaCode" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">City Area Code</link:label>
    <link:label id="lab_dei_CityAreaCode_label_en-US" xlink:label="lab_dei_CityAreaCode" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">City Area Code</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_CityAreaCode" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_CityAreaCode"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_CityAreaCode" xlink:to="lab_dei_CityAreaCode" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_CoverAbstract_label_en-US" xlink:label="lab_dei_CoverAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cover [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_CoverAbstract" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_CoverAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_CoverAbstract" xlink:to="lab_dei_CoverAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_Security12bTitle_3cc04528-71f1-405e-afd4-ca6d2b8fee3b_terseLabel_en-US" xlink:label="lab_dei_Security12bTitle" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Title of 12(b) Security</link:label>
    <link:label id="lab_dei_Security12bTitle_label_en-US" xlink:label="lab_dei_Security12bTitle" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Title of 12(b) Security</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_Security12bTitle" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_Security12bTitle"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_Security12bTitle" xlink:to="lab_dei_Security12bTitle" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_DocumentType_52b0e964-df92-440f-a83d-dad32bbeb701_terseLabel_en-US" xlink:label="lab_dei_DocumentType" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Type</link:label>
    <link:label id="lab_dei_DocumentType_label_en-US" xlink:label="lab_dei_DocumentType" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Type</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentType" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentType"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_DocumentType" xlink:to="lab_dei_DocumentType" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_AmendmentFlag_993b3027-a0ef-4274-a6d4-d631219b6a1a_terseLabel_en-US" xlink:label="lab_dei_AmendmentFlag" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Amendment Flag</link:label>
    <link:label id="lab_dei_AmendmentFlag_label_en-US" xlink:label="lab_dei_AmendmentFlag" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Amendment Flag</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_AmendmentFlag" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_AmendmentFlag"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_AmendmentFlag" xlink:to="lab_dei_AmendmentFlag" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_SecurityExchangeName_74d96c9a-130e-476f-8edb-f45d09eb97fe_terseLabel_en-US" xlink:label="lab_dei_SecurityExchangeName" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Security Exchange Name</link:label>
    <link:label id="lab_dei_SecurityExchangeName_label_en-US" xlink:label="lab_dei_SecurityExchangeName" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Security Exchange Name</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_SecurityExchangeName" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_SecurityExchangeName"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_SecurityExchangeName" xlink:to="lab_dei_SecurityExchangeName" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityRegistrantName_b4d206bd-6ab9-4c4b-95a4-575914439ef9_terseLabel_en-US" xlink:label="lab_dei_EntityRegistrantName" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Registrant Name</link:label>
    <link:label id="lab_dei_EntityRegistrantName_label_en-US" xlink:label="lab_dei_EntityRegistrantName" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Registrant Name</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityRegistrantName" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityRegistrantName"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityRegistrantName" xlink:to="lab_dei_EntityRegistrantName" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityEmergingGrowthCompany_d0af13d0-84fa-4875-9c77-6eb4e1be1ea7_terseLabel_en-US" xlink:label="lab_dei_EntityEmergingGrowthCompany" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Emerging Growth Company</link:label>
    <link:label id="lab_dei_EntityEmergingGrowthCompany_label_en-US" xlink:label="lab_dei_EntityEmergingGrowthCompany" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Emerging Growth Company</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityEmergingGrowthCompany" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityEmergingGrowthCompany"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityEmergingGrowthCompany" xlink:to="lab_dei_EntityEmergingGrowthCompany" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityAddressStateOrProvince_3d4952d0-7753-45c0-b2d4-21a6c0703848_terseLabel_en-US" xlink:label="lab_dei_EntityAddressStateOrProvince" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Address, State or Province</link:label>
    <link:label id="lab_dei_EntityAddressStateOrProvince_label_en-US" xlink:label="lab_dei_EntityAddressStateOrProvince" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Address, State or Province</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressStateOrProvince" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityAddressStateOrProvince"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityAddressStateOrProvince" xlink:to="lab_dei_EntityAddressStateOrProvince" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_DocumentPeriodEndDate_96524eac-e6f4-45aa-b294-d16255b684d5_terseLabel_en-US" xlink:label="lab_dei_DocumentPeriodEndDate" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Period End Date</link:label>
    <link:label id="lab_dei_DocumentPeriodEndDate_label_en-US" xlink:label="lab_dei_DocumentPeriodEndDate" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Period End Date</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentPeriodEndDate" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentPeriodEndDate"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_DocumentPeriodEndDate" xlink:to="lab_dei_DocumentPeriodEndDate" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_PreCommencementTenderOffer_8afa5e22-125b-444f-a790-9e5f52b2d453_terseLabel_en-US" xlink:label="lab_dei_PreCommencementTenderOffer" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Pre-commencement Tender Offer</link:label>
    <link:label id="lab_dei_PreCommencementTenderOffer_label_en-US" xlink:label="lab_dei_PreCommencementTenderOffer" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Pre-commencement Tender Offer</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_PreCommencementTenderOffer" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_PreCommencementTenderOffer"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_PreCommencementTenderOffer" xlink:to="lab_dei_PreCommencementTenderOffer" xlink:type="arc" order="1"/>
  </link:labelLink>
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.PRE
<SEQUENCE>5
<FILENAME>cris-20221109_pre.xml
<DESCRIPTION>XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT
<TEXT>
<XBRL>
<?xml version="1.0" encoding="UTF-8"?>

<!--XBRL Document Created with Wdesk from Workiva-->
<!--Copyright 2022 Workiva-->
<!--r:e81a4c21-32dd-408a-b521-7c1c9605c5b8,g:5cef627b-e60c-4f67-a388-c92bfb9e0bef-->
<link:linkbase xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
  <link:roleRef roleURI="http://www.curis.com/role/CoverPage" xlink:type="simple" xlink:href="cris-20221109.xsd#CoverPage"/>
  <link:presentationLink xlink:role="http://www.curis.com/role/CoverPage" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_dei_CoverAbstract_052cce9b-5990-45a0-829d-50eb7bf25c9e" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_CoverAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentType_d9d77d07-e409-4fc3-b1a0-4c5da6ab2da2" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentType"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_052cce9b-5990-45a0-829d-50eb7bf25c9e" xlink:to="loc_dei_DocumentType_d9d77d07-e409-4fc3-b1a0-4c5da6ab2da2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentPeriodEndDate_ac2206d7-3ad9-403a-a782-91831439b7fc" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentPeriodEndDate"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_052cce9b-5990-45a0-829d-50eb7bf25c9e" xlink:to="loc_dei_DocumentPeriodEndDate_ac2206d7-3ad9-403a-a782-91831439b7fc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityRegistrantName_86b0c771-5e45-40e9-b5b3-686a6a17447e" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityRegistrantName"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_052cce9b-5990-45a0-829d-50eb7bf25c9e" xlink:to="loc_dei_EntityRegistrantName_86b0c771-5e45-40e9-b5b3-686a6a17447e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityIncorporationStateCountryCode_e76c7677-f866-4eb4-ad2f-0335c2015242" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityIncorporationStateCountryCode"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_052cce9b-5990-45a0-829d-50eb7bf25c9e" xlink:to="loc_dei_EntityIncorporationStateCountryCode_e76c7677-f866-4eb4-ad2f-0335c2015242" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityFileNumber_2016203b-0d0f-4fd7-a4f3-d6fb2eb1f4cb" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityFileNumber"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_052cce9b-5990-45a0-829d-50eb7bf25c9e" xlink:to="loc_dei_EntityFileNumber_2016203b-0d0f-4fd7-a4f3-d6fb2eb1f4cb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityTaxIdentificationNumber_6dc2c397-2048-4f51-bda3-9ca7e1ecaeff" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityTaxIdentificationNumber"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_052cce9b-5990-45a0-829d-50eb7bf25c9e" xlink:to="loc_dei_EntityTaxIdentificationNumber_6dc2c397-2048-4f51-bda3-9ca7e1ecaeff" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressAddressLine1_bbc25409-9812-49ee-ad09-408a4cd46a2c" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityAddressAddressLine1"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_052cce9b-5990-45a0-829d-50eb7bf25c9e" xlink:to="loc_dei_EntityAddressAddressLine1_bbc25409-9812-49ee-ad09-408a4cd46a2c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressAddressLine2_061e6bf9-f3a3-452d-b287-9e4a109c4fb3" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityAddressAddressLine2"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_052cce9b-5990-45a0-829d-50eb7bf25c9e" xlink:to="loc_dei_EntityAddressAddressLine2_061e6bf9-f3a3-452d-b287-9e4a109c4fb3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressCityOrTown_b13f1a25-90c2-4c3a-ba4b-a071b64e9aef" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityAddressCityOrTown"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_052cce9b-5990-45a0-829d-50eb7bf25c9e" xlink:to="loc_dei_EntityAddressCityOrTown_b13f1a25-90c2-4c3a-ba4b-a071b64e9aef" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressStateOrProvince_641afa45-1675-41df-b7ef-ebae07c4441f" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityAddressStateOrProvince"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_052cce9b-5990-45a0-829d-50eb7bf25c9e" xlink:to="loc_dei_EntityAddressStateOrProvince_641afa45-1675-41df-b7ef-ebae07c4441f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressPostalZipCode_9ac30344-3920-4706-93ce-0574fae6db32" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityAddressPostalZipCode"/>
    <link:presentationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_052cce9b-5990-45a0-829d-50eb7bf25c9e" xlink:to="loc_dei_EntityAddressPostalZipCode_9ac30344-3920-4706-93ce-0574fae6db32" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_CityAreaCode_34d12510-38f1-4df5-a85e-a9b663f4ba13" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_CityAreaCode"/>
    <link:presentationArc order="12" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_052cce9b-5990-45a0-829d-50eb7bf25c9e" xlink:to="loc_dei_CityAreaCode_34d12510-38f1-4df5-a85e-a9b663f4ba13" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_LocalPhoneNumber_24cda02b-8c37-4b44-88e8-35cde983aa4b" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_LocalPhoneNumber"/>
    <link:presentationArc order="13" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_052cce9b-5990-45a0-829d-50eb7bf25c9e" xlink:to="loc_dei_LocalPhoneNumber_24cda02b-8c37-4b44-88e8-35cde983aa4b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_WrittenCommunications_a3a6b90e-fdd1-4b59-b65e-d4525a878411" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_WrittenCommunications"/>
    <link:presentationArc order="14" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_052cce9b-5990-45a0-829d-50eb7bf25c9e" xlink:to="loc_dei_WrittenCommunications_a3a6b90e-fdd1-4b59-b65e-d4525a878411" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_SolicitingMaterial_33b154a5-8d35-466f-aeb4-ca1d8f070f34" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_SolicitingMaterial"/>
    <link:presentationArc order="15" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_052cce9b-5990-45a0-829d-50eb7bf25c9e" xlink:to="loc_dei_SolicitingMaterial_33b154a5-8d35-466f-aeb4-ca1d8f070f34" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_PreCommencementTenderOffer_f673279e-9188-4e19-8e49-b2d72b30374d" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_PreCommencementTenderOffer"/>
    <link:presentationArc order="16" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_052cce9b-5990-45a0-829d-50eb7bf25c9e" xlink:to="loc_dei_PreCommencementTenderOffer_f673279e-9188-4e19-8e49-b2d72b30374d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_PreCommencementIssuerTenderOffer_fb3e0e9b-ff12-47d1-aceb-b651d20988bb" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_PreCommencementIssuerTenderOffer"/>
    <link:presentationArc order="17" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_052cce9b-5990-45a0-829d-50eb7bf25c9e" xlink:to="loc_dei_PreCommencementIssuerTenderOffer_fb3e0e9b-ff12-47d1-aceb-b651d20988bb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_Security12bTitle_ddd5d5c3-7c20-4f3a-ad13-30d6cf933094" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_Security12bTitle"/>
    <link:presentationArc order="18" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_052cce9b-5990-45a0-829d-50eb7bf25c9e" xlink:to="loc_dei_Security12bTitle_ddd5d5c3-7c20-4f3a-ad13-30d6cf933094" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_TradingSymbol_05cdb59d-2dd0-49cb-8752-a33dea852f0c" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_TradingSymbol"/>
    <link:presentationArc order="19" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_052cce9b-5990-45a0-829d-50eb7bf25c9e" xlink:to="loc_dei_TradingSymbol_05cdb59d-2dd0-49cb-8752-a33dea852f0c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_SecurityExchangeName_14b4e714-f9a4-46a1-bc2f-e9f9fa919a6a" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_SecurityExchangeName"/>
    <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_052cce9b-5990-45a0-829d-50eb7bf25c9e" xlink:to="loc_dei_SecurityExchangeName_14b4e714-f9a4-46a1-bc2f-e9f9fa919a6a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityEmergingGrowthCompany_aaad2696-b86b-4976-b309-7ef854794dd7" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityEmergingGrowthCompany"/>
    <link:presentationArc order="21" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_052cce9b-5990-45a0-829d-50eb7bf25c9e" xlink:to="loc_dei_EntityEmergingGrowthCompany_aaad2696-b86b-4976-b309-7ef854794dd7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityCentralIndexKey_195d43e6-58c8-4969-bd29-ca22e279748f" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityCentralIndexKey"/>
    <link:presentationArc order="22" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_052cce9b-5990-45a0-829d-50eb7bf25c9e" xlink:to="loc_dei_EntityCentralIndexKey_195d43e6-58c8-4969-bd29-ca22e279748f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_AmendmentFlag_4e567652-2aaa-4a16-9a60-e8fcfc3ce040" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_AmendmentFlag"/>
    <link:presentationArc order="23" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_052cce9b-5990-45a0-829d-50eb7bf25c9e" xlink:to="loc_dei_AmendmentFlag_4e567652-2aaa-4a16-9a60-e8fcfc3ce040" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>6
<FILENAME>image_0a.jpg
<TEXT>
begin 644 image_0a.jpg
M_]C_X  02D9)1@ ! 0$ W #<  #_VP!#  (! 0$! 0(! 0$" @(" @0# @("
M @4$! ,$!@4&!@8%!@8&!PD(!@<)!P8&" L("0H*"@H*!@@+# L*# D*"@K_
MVP!# 0(" @(" @4# P4*!P8'"@H*"@H*"@H*"@H*"@H*"@H*"@H*"@H*"@H*
M"@H*"@H*"@H*"@H*"@H*"@H*"@H*"@K_P  1" "* 0L# 2(  A$! Q$!_\0
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M<U4Y=KZ>B2UD_P /(_'\9QKQ-Q'B)8?)*3C'NE>7JV](_P!:GDOQ:_X*N?\
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M7!S2U\>?=&3XQ\/7GBSPS>>'[#Q5J6BS74>Q=4TCR?M-OR,F/SHY$!(XR4.
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MNKX@7WAK5]:&DWFFZY=6\DUI<-"\L9618UWJPBFS\ORX'/(K]6" >37YW_\
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MMJ\+,L1'%9A6K1VE*37HVV?193AYX3*Z%">\813]4D@K\[_^#EK)_84\-_\
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MB&,#QW%D G'+>;>0\<?+N.>,'[PT?3K;2=+M]*LXMD-M;K%"NXG:JK@#)Y/
MKA?VKO@;IW[2_P"SIXR^!6INJ+XDT&>TAED^[%,5S$_0XVR!6R 2,<<UU91B
MHY?FE&N]HR3?I?7\#CSO!RS+):V'6\X-+UMI^)^,_P#P;B^+M.\-_M^7VB7K
M8FU[X?W]E9^\BW%K<'_QR!Z_=ZOYB_V?/B7\0/\ @GU^VOH_C+Q?X?O+/5O
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<UI7E)W;/TS!X/#Y?A88>A'EA%62"BBBN<ZC_V0$!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>7
<FILENAME>R1.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.2.2</span><table class="report" border="0" cellspacing="2" id="idm140452214073600">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Cover Page<br></strong></div></th>
<th class="th"><div>Nov. 09, 2022</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_CoverAbstract', window );"><strong>Cover [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_DocumentType', window );">Document Type</a></td>
<td class="text">8-K<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_DocumentPeriodEndDate', window );">Document Period End Date</a></td>
<td class="text">Nov.  09,  2022<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityRegistrantName', window );">Entity Registrant Name</a></td>
<td class="text">Curis, Inc.<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityIncorporationStateCountryCode', window );">Entity Incorporation, State or Country Code</a></td>
<td class="text">DE<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityFileNumber', window );">Entity File Number</a></td>
<td class="text">000-30347<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityTaxIdentificationNumber', window );">Entity Tax Identification Number</a></td>
<td class="text">04-3505116<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressAddressLine1', window );">Entity Address, Address Line One</a></td>
<td class="text">128 Spring Street<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressAddressLine2', window );">Entity Address, Address Line Two</a></td>
<td class="text">Building C - Suite 500<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressCityOrTown', window );">Entity Address, City or Town</a></td>
<td class="text">Lexington<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressStateOrProvince', window );">Entity Address, State or Province</a></td>
<td class="text">MA<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressPostalZipCode', window );">Entity Address, Postal Zip Code</a></td>
<td class="text">02421<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_CityAreaCode', window );">City Area Code</a></td>
<td class="text">(617)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_LocalPhoneNumber', window );">Local Phone Number</a></td>
<td class="text">503-6500<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_WrittenCommunications', window );">Written Communications</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_SolicitingMaterial', window );">Soliciting Material</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_PreCommencementTenderOffer', window );">Pre-commencement Tender Offer</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_PreCommencementIssuerTenderOffer', window );">Pre-commencement Issuer Tender Offer</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_Security12bTitle', window );">Title of 12(b) Security</a></td>
<td class="text">Common Stock, Par Value $0.01 per share<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_TradingSymbol', window );">Trading Symbol</a></td>
<td class="text">CRIS<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_SecurityExchangeName', window );">Security Exchange Name</a></td>
<td class="text">NASDAQ<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityEmergingGrowthCompany', window );">Entity Emerging Growth Company</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityCentralIndexKey', window );">Entity Central Index Key</a></td>
<td class="text">0001108205<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_AmendmentFlag', window );">Amendment Flag</a></td>
<td class="text">false<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_AmendmentFlag">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the XBRL content amends previously-filed or accepted submission.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_AmendmentFlag</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_CityAreaCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Area code of city</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_CityAreaCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_CoverAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Cover page.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_CoverAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentPeriodEndDate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>For the EDGAR submission types of Form 8-K: the date of the report, the date of the earliest event reported; for the EDGAR submission types of Form N-1A: the filing date; for all other submission types: the end of the reporting or transition period.  The format of the date is YYYY-MM-DD.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentPeriodEndDate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:dateItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentType">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentType</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:submissionTypeItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressAddressLine1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Address Line 1 such as Attn, Building Name, Street Name</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressAddressLine1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressAddressLine2">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Address Line 2 such as Street or Suite number</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressAddressLine2</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressCityOrTown">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Name of the City or Town</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressCityOrTown</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressPostalZipCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Code for the postal or zip code</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressPostalZipCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressStateOrProvince">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Name of the state or province.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressStateOrProvince</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:stateOrProvinceItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityCentralIndexKey">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityCentralIndexKey</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:centralIndexKeyItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityEmergingGrowthCompany">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Indicate if registrant meets the emerging growth company criteria.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityEmergingGrowthCompany</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityFileNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityFileNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:fileNumberItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityIncorporationStateCountryCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Two-character EDGAR code representing the state or country of incorporation.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityIncorporationStateCountryCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:edgarStateCountryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityRegistrantName">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityRegistrantName</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityTaxIdentificationNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The Tax Identification Number (TIN), also known as an Employer Identification Number (EIN), is a unique 9-digit value assigned by the IRS.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityTaxIdentificationNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:employerIdItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_LocalPhoneNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Local phone number for entity.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_LocalPhoneNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_PreCommencementIssuerTenderOffer">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 13e<br> -Subsection 4c<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_PreCommencementIssuerTenderOffer</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_PreCommencementTenderOffer">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 14d<br> -Subsection 2b<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_PreCommencementTenderOffer</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_Security12bTitle">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Title of a 12(b) registered security.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_Security12bTitle</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:securityTitleItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_SecurityExchangeName">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Name of the Exchange on which a security is registered.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection d1-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_SecurityExchangeName</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:edgarExchangeCodeItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_SolicitingMaterial">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as soliciting material pursuant to Rule 14a-12 under the Exchange Act.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Section 14a<br> -Number 240<br> -Subsection 12<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_SolicitingMaterial</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_TradingSymbol">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Trading symbol of an instrument as listed on an exchange.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_TradingSymbol</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:tradingSymbolItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_WrittenCommunications">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as written communications pursuant to Rule 425 under the Securities Act.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Securities Act<br> -Number 230<br> -Section 425<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_WrittenCommunications</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>8
<FILENAME>cris-20221109_htm.xml
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<XML>
<?xml version="1.0" encoding="utf-8"?>
<xbrl
  xml:lang="en-US"
  xmlns="http://www.xbrl.org/2003/instance"
  xmlns:dei="http://xbrl.sec.gov/dei/2022"
  xmlns:link="http://www.xbrl.org/2003/linkbase"
  xmlns:xlink="http://www.w3.org/1999/xlink">
    <link:schemaRef xlink:href="cris-20221109.xsd" xlink:type="simple"/>
    <context id="i65fa79e006574b989ada023c81fde3ea_D20221109-20221109">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001108205</identifier>
        </entity>
        <period>
            <startDate>2022-11-09</startDate>
            <endDate>2022-11-09</endDate>
        </period>
    </context>
    <dei:EntityCentralIndexKey
      contextRef="i65fa79e006574b989ada023c81fde3ea_D20221109-20221109"
      id="id3VybDovL2RvY3MudjEvZG9jOjhlMDliZDgxZjU3YjQ1MzVhOTc2M2EwZmYwZTY3ODFiL3NlYzo4ZTA5YmQ4MWY1N2I0NTM1YTk3NjNhMGZmMGU2NzgxYl80L2ZyYWc6NzIwZGNmYjZlOGFlNDFjM2IwZWE4YjViZGJmODU5NmIvdGFibGU6M2YyOTFiNTU2Y2UwNDUzZWJlYTkwNWI4ZmYwZTNkNzcvdGFibGVyYW5nZTozZjI5MWI1NTZjZTA0NTNlYmVhOTA1YjhmZjBlM2Q3N18wLTEtMS0xLTI4MjQ3_63fa852d-0fab-4d1a-8b29-54f994002831">0001108205</dei:EntityCentralIndexKey>
    <dei:AmendmentFlag
      contextRef="i65fa79e006574b989ada023c81fde3ea_D20221109-20221109"
      id="id3VybDovL2RvY3MudjEvZG9jOjhlMDliZDgxZjU3YjQ1MzVhOTc2M2EwZmYwZTY3ODFiL3NlYzo4ZTA5YmQ4MWY1N2I0NTM1YTk3NjNhMGZmMGU2NzgxYl80L2ZyYWc6NzIwZGNmYjZlOGFlNDFjM2IwZWE4YjViZGJmODU5NmIvdGFibGU6M2YyOTFiNTU2Y2UwNDUzZWJlYTkwNWI4ZmYwZTNkNzcvdGFibGVyYW5nZTozZjI5MWI1NTZjZTA0NTNlYmVhOTA1YjhmZjBlM2Q3N18xLTEtMS0xLTI4MjQ3_1f66e096-253e-4039-8b22-34324e3b596c">false</dei:AmendmentFlag>
    <dei:DocumentType
      contextRef="i65fa79e006574b989ada023c81fde3ea_D20221109-20221109"
      id="id3VybDovL2RvY3MudjEvZG9jOjhlMDliZDgxZjU3YjQ1MzVhOTc2M2EwZmYwZTY3ODFiL3NlYzo4ZTA5YmQ4MWY1N2I0NTM1YTk3NjNhMGZmMGU2NzgxYl8xL2ZyYWc6MDFiOTlmNWU2ZGNkNDYwMDk2YjNlMTkwOGI0MmQzODAvdGV4dHJlZ2lvbjowMWI5OWY1ZTZkY2Q0NjAwOTZiM2UxOTA4YjQyZDM4MF8xMDc2_efae3acd-c7c1-4977-bd0c-944dd89e1610">8-K</dei:DocumentType>
    <dei:DocumentPeriodEndDate
      contextRef="i65fa79e006574b989ada023c81fde3ea_D20221109-20221109"
      id="id3VybDovL2RvY3MudjEvZG9jOjhlMDliZDgxZjU3YjQ1MzVhOTc2M2EwZmYwZTY3ODFiL3NlYzo4ZTA5YmQ4MWY1N2I0NTM1YTk3NjNhMGZmMGU2NzgxYl8xL2ZyYWc6MDFiOTlmNWU2ZGNkNDYwMDk2YjNlMTkwOGI0MmQzODAvdGV4dHJlZ2lvbjowMWI5OWY1ZTZkY2Q0NjAwOTZiM2UxOTA4YjQyZDM4MF8xMDk5NTExNjI4ODYw_6a5dddfa-134d-4817-a35d-27db4fd9b9f5">2022-11-09</dei:DocumentPeriodEndDate>
    <dei:EntityRegistrantName
      contextRef="i65fa79e006574b989ada023c81fde3ea_D20221109-20221109"
      id="id3VybDovL2RvY3MudjEvZG9jOjhlMDliZDgxZjU3YjQ1MzVhOTc2M2EwZmYwZTY3ODFiL3NlYzo4ZTA5YmQ4MWY1N2I0NTM1YTk3NjNhMGZmMGU2NzgxYl8xL2ZyYWc6MDFiOTlmNWU2ZGNkNDYwMDk2YjNlMTkwOGI0MmQzODAvdGV4dHJlZ2lvbjowMWI5OWY1ZTZkY2Q0NjAwOTZiM2UxOTA4YjQyZDM4MF8xMDcy_5d493a22-5631-4ff1-a14f-b0f510529b05">Curis, Inc.</dei:EntityRegistrantName>
    <dei:EntityIncorporationStateCountryCode
      contextRef="i65fa79e006574b989ada023c81fde3ea_D20221109-20221109"
      id="id3VybDovL2RvY3MudjEvZG9jOjhlMDliZDgxZjU3YjQ1MzVhOTc2M2EwZmYwZTY3ODFiL3NlYzo4ZTA5YmQ4MWY1N2I0NTM1YTk3NjNhMGZmMGU2NzgxYl8xL2ZyYWc6MDFiOTlmNWU2ZGNkNDYwMDk2YjNlMTkwOGI0MmQzODAvdGFibGU6M2VhNmZhYWU3NDdiNDAyOTk1ODBjOWY4OTY3NGExZDQvdGFibGVyYW5nZTozZWE2ZmFhZTc0N2I0MDI5OTU4MGM5Zjg5Njc0YTFkNF8wLTAtMS0xLTI4MjQ3_1c1f076c-8435-4c3f-a086-d18d61a4198b">DE</dei:EntityIncorporationStateCountryCode>
    <dei:EntityFileNumber
      contextRef="i65fa79e006574b989ada023c81fde3ea_D20221109-20221109"
      id="id3VybDovL2RvY3MudjEvZG9jOjhlMDliZDgxZjU3YjQ1MzVhOTc2M2EwZmYwZTY3ODFiL3NlYzo4ZTA5YmQ4MWY1N2I0NTM1YTk3NjNhMGZmMGU2NzgxYl8xL2ZyYWc6MDFiOTlmNWU2ZGNkNDYwMDk2YjNlMTkwOGI0MmQzODAvdGFibGU6M2VhNmZhYWU3NDdiNDAyOTk1ODBjOWY4OTY3NGExZDQvdGFibGVyYW5nZTozZWE2ZmFhZTc0N2I0MDI5OTU4MGM5Zjg5Njc0YTFkNF8wLTEtMS0xLTI4MjQ3_63685aa4-daf9-4c86-a89d-ea81f1c9b7a1">000-30347</dei:EntityFileNumber>
    <dei:EntityTaxIdentificationNumber
      contextRef="i65fa79e006574b989ada023c81fde3ea_D20221109-20221109"
      id="id3VybDovL2RvY3MudjEvZG9jOjhlMDliZDgxZjU3YjQ1MzVhOTc2M2EwZmYwZTY3ODFiL3NlYzo4ZTA5YmQ4MWY1N2I0NTM1YTk3NjNhMGZmMGU2NzgxYl8xL2ZyYWc6MDFiOTlmNWU2ZGNkNDYwMDk2YjNlMTkwOGI0MmQzODAvdGFibGU6M2VhNmZhYWU3NDdiNDAyOTk1ODBjOWY4OTY3NGExZDQvdGFibGVyYW5nZTozZWE2ZmFhZTc0N2I0MDI5OTU4MGM5Zjg5Njc0YTFkNF8wLTItMS0xLTI4MjQ3_dfbd240d-6c2f-44e0-8cfa-f6d2e2c24424">04-3505116</dei:EntityTaxIdentificationNumber>
    <dei:EntityAddressAddressLine1
      contextRef="i65fa79e006574b989ada023c81fde3ea_D20221109-20221109"
      id="id3VybDovL2RvY3MudjEvZG9jOjhlMDliZDgxZjU3YjQ1MzVhOTc2M2EwZmYwZTY3ODFiL3NlYzo4ZTA5YmQ4MWY1N2I0NTM1YTk3NjNhMGZmMGU2NzgxYl8xL2ZyYWc6MDFiOTlmNWU2ZGNkNDYwMDk2YjNlMTkwOGI0MmQzODAvdGFibGU6YjI0MDY1MWUwNTc3NGQyY2EzZjNjZDc3NGMzMTRjMjUvdGFibGVyYW5nZTpiMjQwNjUxZTA1Nzc0ZDJjYTNmM2NkNzc0YzMxNGMyNV8wLTAtMS0xLTI4MjQ3L3RleHRyZWdpb246MjA4NjU1NDQ2ODljNGI5M2FjZmFhN2Y2MGZkNGY4ZDVfNA_8e3467c3-471a-4331-b411-501e1f406f8c">128 Spring Street</dei:EntityAddressAddressLine1>
    <dei:EntityAddressAddressLine2
      contextRef="i65fa79e006574b989ada023c81fde3ea_D20221109-20221109"
      id="id3VybDovL2RvY3MudjEvZG9jOjhlMDliZDgxZjU3YjQ1MzVhOTc2M2EwZmYwZTY3ODFiL3NlYzo4ZTA5YmQ4MWY1N2I0NTM1YTk3NjNhMGZmMGU2NzgxYl8xL2ZyYWc6MDFiOTlmNWU2ZGNkNDYwMDk2YjNlMTkwOGI0MmQzODAvdGFibGU6YjI0MDY1MWUwNTc3NGQyY2EzZjNjZDc3NGMzMTRjMjUvdGFibGVyYW5nZTpiMjQwNjUxZTA1Nzc0ZDJjYTNmM2NkNzc0YzMxNGMyNV8wLTAtMS0xLTI4MjQ3L3RleHRyZWdpb246MjA4NjU1NDQ2ODljNGI5M2FjZmFhN2Y2MGZkNGY4ZDVfOA_d8b7f88a-d859-444e-b143-d6e067d1d6a8">Building C - Suite 500</dei:EntityAddressAddressLine2>
    <dei:EntityAddressCityOrTown
      contextRef="i65fa79e006574b989ada023c81fde3ea_D20221109-20221109"
      id="id3VybDovL2RvY3MudjEvZG9jOjhlMDliZDgxZjU3YjQ1MzVhOTc2M2EwZmYwZTY3ODFiL3NlYzo4ZTA5YmQ4MWY1N2I0NTM1YTk3NjNhMGZmMGU2NzgxYl8xL2ZyYWc6MDFiOTlmNWU2ZGNkNDYwMDk2YjNlMTkwOGI0MmQzODAvdGFibGU6YjI0MDY1MWUwNTc3NGQyY2EzZjNjZDc3NGMzMTRjMjUvdGFibGVyYW5nZTpiMjQwNjUxZTA1Nzc0ZDJjYTNmM2NkNzc0YzMxNGMyNV8wLTAtMS0xLTI4MjQ3L3RleHRyZWdpb246MjA4NjU1NDQ2ODljNGI5M2FjZmFhN2Y2MGZkNGY4ZDVfMTI_c92e8b7f-ccd7-47d5-90ec-b949e4deceef">Lexington</dei:EntityAddressCityOrTown>
    <dei:EntityAddressStateOrProvince
      contextRef="i65fa79e006574b989ada023c81fde3ea_D20221109-20221109"
      id="id3VybDovL2RvY3MudjEvZG9jOjhlMDliZDgxZjU3YjQ1MzVhOTc2M2EwZmYwZTY3ODFiL3NlYzo4ZTA5YmQ4MWY1N2I0NTM1YTk3NjNhMGZmMGU2NzgxYl8xL2ZyYWc6MDFiOTlmNWU2ZGNkNDYwMDk2YjNlMTkwOGI0MmQzODAvdGFibGU6YjI0MDY1MWUwNTc3NGQyY2EzZjNjZDc3NGMzMTRjMjUvdGFibGVyYW5nZTpiMjQwNjUxZTA1Nzc0ZDJjYTNmM2NkNzc0YzMxNGMyNV8wLTAtMS0xLTI4MjQ3L3RleHRyZWdpb246MjA4NjU1NDQ2ODljNGI5M2FjZmFhN2Y2MGZkNGY4ZDVfMTY_641ac630-f1f3-440e-830a-da66247d561a">MA</dei:EntityAddressStateOrProvince>
    <dei:EntityAddressPostalZipCode
      contextRef="i65fa79e006574b989ada023c81fde3ea_D20221109-20221109"
      id="id3VybDovL2RvY3MudjEvZG9jOjhlMDliZDgxZjU3YjQ1MzVhOTc2M2EwZmYwZTY3ODFiL3NlYzo4ZTA5YmQ4MWY1N2I0NTM1YTk3NjNhMGZmMGU2NzgxYl8xL2ZyYWc6MDFiOTlmNWU2ZGNkNDYwMDk2YjNlMTkwOGI0MmQzODAvdGFibGU6YjI0MDY1MWUwNTc3NGQyY2EzZjNjZDc3NGMzMTRjMjUvdGFibGVyYW5nZTpiMjQwNjUxZTA1Nzc0ZDJjYTNmM2NkNzc0YzMxNGMyNV8wLTAtMS0xLTI4MjQ3L3RleHRyZWdpb246MjA4NjU1NDQ2ODljNGI5M2FjZmFhN2Y2MGZkNGY4ZDVfMTk_f7cad213-2f6c-48d5-9284-e9d27082f25a">02421</dei:EntityAddressPostalZipCode>
    <dei:CityAreaCode
      contextRef="i65fa79e006574b989ada023c81fde3ea_D20221109-20221109"
      id="id3VybDovL2RvY3MudjEvZG9jOjhlMDliZDgxZjU3YjQ1MzVhOTc2M2EwZmYwZTY3ODFiL3NlYzo4ZTA5YmQ4MWY1N2I0NTM1YTk3NjNhMGZmMGU2NzgxYl8xL2ZyYWc6MDFiOTlmNWU2ZGNkNDYwMDk2YjNlMTkwOGI0MmQzODAvdGV4dHJlZ2lvbjowMWI5OWY1ZTZkY2Q0NjAwOTZiM2UxOTA4YjQyZDM4MF8xMDcz_5a071340-91d4-477f-bef7-b07e6ea8364a">(617)</dei:CityAreaCode>
    <dei:LocalPhoneNumber
      contextRef="i65fa79e006574b989ada023c81fde3ea_D20221109-20221109"
      id="id3VybDovL2RvY3MudjEvZG9jOjhlMDliZDgxZjU3YjQ1MzVhOTc2M2EwZmYwZTY3ODFiL3NlYzo4ZTA5YmQ4MWY1N2I0NTM1YTk3NjNhMGZmMGU2NzgxYl8xL2ZyYWc6MDFiOTlmNWU2ZGNkNDYwMDk2YjNlMTkwOGI0MmQzODAvdGV4dHJlZ2lvbjowMWI5OWY1ZTZkY2Q0NjAwOTZiM2UxOTA4YjQyZDM4MF8xMDc0_7949a085-fee7-4365-9d9b-78dddaa55abf">503-6500</dei:LocalPhoneNumber>
    <dei:WrittenCommunications
      contextRef="i65fa79e006574b989ada023c81fde3ea_D20221109-20221109"
      id="id3VybDovL2RvY3MudjEvZG9jOjhlMDliZDgxZjU3YjQ1MzVhOTc2M2EwZmYwZTY3ODFiL3NlYzo4ZTA5YmQ4MWY1N2I0NTM1YTk3NjNhMGZmMGU2NzgxYl8xL2ZyYWc6MDFiOTlmNWU2ZGNkNDYwMDk2YjNlMTkwOGI0MmQzODAvdGFibGU6NzlhOWZhNjU2ZGEzNGE0ODk5NDFjZGYzYzI5OWRkZDEvdGFibGVyYW5nZTo3OWE5ZmE2NTZkYTM0YTQ4OTk0MWNkZjNjMjk5ZGRkMV8xLTEtMS0xLTI4MjQ3_6d238c4d-997a-48cf-bbc7-9628f04deca7">false</dei:WrittenCommunications>
    <dei:SolicitingMaterial
      contextRef="i65fa79e006574b989ada023c81fde3ea_D20221109-20221109"
      id="id3VybDovL2RvY3MudjEvZG9jOjhlMDliZDgxZjU3YjQ1MzVhOTc2M2EwZmYwZTY3ODFiL3NlYzo4ZTA5YmQ4MWY1N2I0NTM1YTk3NjNhMGZmMGU2NzgxYl8xL2ZyYWc6MDFiOTlmNWU2ZGNkNDYwMDk2YjNlMTkwOGI0MmQzODAvdGFibGU6NzlhOWZhNjU2ZGEzNGE0ODk5NDFjZGYzYzI5OWRkZDEvdGFibGVyYW5nZTo3OWE5ZmE2NTZkYTM0YTQ4OTk0MWNkZjNjMjk5ZGRkMV8yLTEtMS0xLTI4MjQ3_9eecdb22-082a-4fbc-8854-b47abf8fc26c">false</dei:SolicitingMaterial>
    <dei:PreCommencementTenderOffer
      contextRef="i65fa79e006574b989ada023c81fde3ea_D20221109-20221109"
      id="id3VybDovL2RvY3MudjEvZG9jOjhlMDliZDgxZjU3YjQ1MzVhOTc2M2EwZmYwZTY3ODFiL3NlYzo4ZTA5YmQ4MWY1N2I0NTM1YTk3NjNhMGZmMGU2NzgxYl8xL2ZyYWc6MDFiOTlmNWU2ZGNkNDYwMDk2YjNlMTkwOGI0MmQzODAvdGFibGU6NzlhOWZhNjU2ZGEzNGE0ODk5NDFjZGYzYzI5OWRkZDEvdGFibGVyYW5nZTo3OWE5ZmE2NTZkYTM0YTQ4OTk0MWNkZjNjMjk5ZGRkMV8zLTEtMS0xLTI4MjQ3_aa58cf30-96f7-4c13-8cce-ed0238302268">false</dei:PreCommencementTenderOffer>
    <dei:PreCommencementIssuerTenderOffer
      contextRef="i65fa79e006574b989ada023c81fde3ea_D20221109-20221109"
      id="id3VybDovL2RvY3MudjEvZG9jOjhlMDliZDgxZjU3YjQ1MzVhOTc2M2EwZmYwZTY3ODFiL3NlYzo4ZTA5YmQ4MWY1N2I0NTM1YTk3NjNhMGZmMGU2NzgxYl8xL2ZyYWc6MDFiOTlmNWU2ZGNkNDYwMDk2YjNlMTkwOGI0MmQzODAvdGFibGU6NzlhOWZhNjU2ZGEzNGE0ODk5NDFjZGYzYzI5OWRkZDEvdGFibGVyYW5nZTo3OWE5ZmE2NTZkYTM0YTQ4OTk0MWNkZjNjMjk5ZGRkMV80LTEtMS0xLTI4MjQ3_289bc854-2251-481d-bedc-ba1913770259">false</dei:PreCommencementIssuerTenderOffer>
    <dei:Security12bTitle
      contextRef="i65fa79e006574b989ada023c81fde3ea_D20221109-20221109"
      id="id3VybDovL2RvY3MudjEvZG9jOjhlMDliZDgxZjU3YjQ1MzVhOTc2M2EwZmYwZTY3ODFiL3NlYzo4ZTA5YmQ4MWY1N2I0NTM1YTk3NjNhMGZmMGU2NzgxYl8xL2ZyYWc6MDFiOTlmNWU2ZGNkNDYwMDk2YjNlMTkwOGI0MmQzODAvdGFibGU6ZTNmYzE3YzcyM2Y1NDNiZmI5YjY1OTBiYWZhZjcyODQvdGFibGVyYW5nZTplM2ZjMTdjNzIzZjU0M2JmYjliNjU5MGJhZmFmNzI4NF8xLTAtMS0xLTI4MjQ3_0531256e-8633-45b1-b673-4e8ef46ff48c">Common Stock, Par Value $0.01 per share</dei:Security12bTitle>
    <dei:TradingSymbol
      contextRef="i65fa79e006574b989ada023c81fde3ea_D20221109-20221109"
      id="id3VybDovL2RvY3MudjEvZG9jOjhlMDliZDgxZjU3YjQ1MzVhOTc2M2EwZmYwZTY3ODFiL3NlYzo4ZTA5YmQ4MWY1N2I0NTM1YTk3NjNhMGZmMGU2NzgxYl8xL2ZyYWc6MDFiOTlmNWU2ZGNkNDYwMDk2YjNlMTkwOGI0MmQzODAvdGFibGU6ZTNmYzE3YzcyM2Y1NDNiZmI5YjY1OTBiYWZhZjcyODQvdGFibGVyYW5nZTplM2ZjMTdjNzIzZjU0M2JmYjliNjU5MGJhZmFmNzI4NF8xLTItMS0xLTI4MjQ3_b913cec2-78d7-4bf9-88ab-391b76197fc7">CRIS</dei:TradingSymbol>
    <dei:SecurityExchangeName
      contextRef="i65fa79e006574b989ada023c81fde3ea_D20221109-20221109"
      id="id3VybDovL2RvY3MudjEvZG9jOjhlMDliZDgxZjU3YjQ1MzVhOTc2M2EwZmYwZTY3ODFiL3NlYzo4ZTA5YmQ4MWY1N2I0NTM1YTk3NjNhMGZmMGU2NzgxYl8xL2ZyYWc6MDFiOTlmNWU2ZGNkNDYwMDk2YjNlMTkwOGI0MmQzODAvdGFibGU6ZTNmYzE3YzcyM2Y1NDNiZmI5YjY1OTBiYWZhZjcyODQvdGFibGVyYW5nZTplM2ZjMTdjNzIzZjU0M2JmYjliNjU5MGJhZmFmNzI4NF8xLTQtMS0xLTI4MjQ3_7101adf3-d323-4cf7-83a2-eff2d58ef90a">NASDAQ</dei:SecurityExchangeName>
    <dei:EntityEmergingGrowthCompany
      contextRef="i65fa79e006574b989ada023c81fde3ea_D20221109-20221109"
      id="id3VybDovL2RvY3MudjEvZG9jOjhlMDliZDgxZjU3YjQ1MzVhOTc2M2EwZmYwZTY3ODFiL3NlYzo4ZTA5YmQ4MWY1N2I0NTM1YTk3NjNhMGZmMGU2NzgxYl8xL2ZyYWc6MDFiOTlmNWU2ZGNkNDYwMDk2YjNlMTkwOGI0MmQzODAvdGV4dHJlZ2lvbjowMWI5OWY1ZTZkY2Q0NjAwOTZiM2UxOTA4YjQyZDM4MF8xMDc1_0ab78761-6ade-4522-b6a3-5bc535d3a732">false</dei:EntityEmergingGrowthCompany>
</xbrl>
</XML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EXCEL
<SEQUENCE>9
<FILENAME>Financial_Report.xlsx
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
begin 644 Financial_Report.xlsx
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M!;IZ?RK?-XQ*BY/P0ADX5Q>W:\[ +^P+\/U2*?/>L(?K\K^1T=]02P,$%
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M$MP>:4#M.*2VBZD8_1!2:5K5N %(MB6/:<Z10J[4+!XUA]) 1-MC0[!:+#Y
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M4$L! A0#%     @ 0X!I53^,N"SN    *P(  !$              ( !KP
M &1O8U!R;W!S+V-O<F4N>&UL4$L! A0#%     @ 0X!I59E<G",0!@  G"<
M !,              ( !S $  'AL+W1H96UE+W1H96UE,2YX;6Q02P$"% ,4
M    " !#@&E57G%+F5X$   G$0  &               @($-"   >&PO=V]R
M:W-H965T<R]S:&5E=#$N>&UL4$L! A0#%     @ 0X!I59^@&_"Q @  X@P
M  T              ( !H0P  'AL+W-T>6QE<RYX;6Q02P$"% ,4    " !#
M@&E5EXJ[',     3 @  "P              @ %]#P  7W)E;',O+G)E;'-0
M2P$"% ,4    " !#@&E5&445]3<!   G @  #P              @ %F$
M>&PO=V]R:V)O;VLN>&UL4$L! A0#%     @ 0X!I520>FZ*M    ^ $  !H
M             ( !RA$  'AL+U]R96QS+W=O<FMB;V]K+GAM;"YR96QS4$L!
M A0#%     @ 0X!I5660>9(9 0  SP,  !,              ( !KQ(  %M#
G;VYT96YT7U1Y<&5S72YX;6Q02P4&      D "0 ^ @  ^1,

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>10
<FILENAME>Show.js
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
// Edgar(tm) Renderer was created by staff of the U.S. Securities and Exchange Commission.  Data and content created by government employees within the scope of their employment are not subject to domestic copyright protection. 17 U.S.C. 105.
var Show={};Show.LastAR=null,Show.showAR=function(a,r,w){if(Show.LastAR)Show.hideAR();var e=a;while(e&&e.nodeName!='TABLE')e=e.nextSibling;if(!e||e.nodeName!='TABLE'){var ref=((window)?w.document:document).getElementById(r);if(ref){e=ref.cloneNode(!0);
e.removeAttribute('id');a.parentNode.appendChild(e)}}
if(e)e.style.display='block';Show.LastAR=e};Show.hideAR=function(){Show.LastAR.style.display='none'};Show.toggleNext=function(a){var e=a;while(e.nodeName!='DIV')e=e.nextSibling;if(!e.style){}else if(!e.style.display){}else{var d,p_;if(e.style.display=='none'){d='block';p='-'}else{d='none';p='+'}
e.style.display=d;if(a.textContent){a.textContent=p+a.textContent.substring(1)}else{a.innerText=p+a.innerText.substring(1)}}}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>11
<FILENAME>report.css
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
/* Updated 2009-11-04 */
/* v2.2.0.24 */

/* DefRef Styles */
..report table.authRefData{
	background-color: #def;
	border: 2px solid #2F4497;
	font-size: 1em;
	position: absolute;
}

..report table.authRefData a {
	display: block;
	font-weight: bold;
}

..report table.authRefData p {
	margin-top: 0px;
}

..report table.authRefData .hide {
	background-color: #2F4497;
	padding: 1px 3px 0px 0px;
	text-align: right;
}

..report table.authRefData .hide a:hover {
	background-color: #2F4497;
}

..report table.authRefData .body {
	height: 150px;
	overflow: auto;
	width: 400px;
}

..report table.authRefData table{
	font-size: 1em;
}

/* Report Styles */
..pl a, .pl a:visited {
	color: black;
	text-decoration: none;
}

/* table */
..report {
	background-color: white;
	border: 2px solid #acf;
	clear: both;
	color: black;
	font: normal 8pt Helvetica, Arial, san-serif;
	margin-bottom: 2em;
}

..report hr {
	border: 1px solid #acf;
}

/* Top labels */
..report th {
	background-color: #acf;
	color: black;
	font-weight: bold;
	text-align: center;
}

..report th.void	{
	background-color: transparent;
	color: #000000;
	font: bold 10pt Helvetica, Arial, san-serif;
	text-align: left;
}

..report .pl {
	text-align: left;
	vertical-align: top;
	white-space: normal;
	width: 200px;
	white-space: normal; /* word-wrap: break-word; */
}

..report td.pl a.a {
	cursor: pointer;
	display: block;
	width: 200px;
	overflow: hidden;
}

..report td.pl div.a {
	width: 200px;
}

..report td.pl a:hover {
	background-color: #ffc;
}

/* Header rows... */
..report tr.rh {
	background-color: #acf;
	color: black;
	font-weight: bold;
}

/* Calendars... */
..report .rc {
	background-color: #f0f0f0;
}

/* Even rows... */
..report .re, .report .reu {
	background-color: #def;
}

..report .reu td {
	border-bottom: 1px solid black;
}

/* Odd rows... */
..report .ro, .report .rou {
	background-color: white;
}

..report .rou td {
	border-bottom: 1px solid black;
}

..report .rou table td, .report .reu table td {
	border-bottom: 0px solid black;
}

/* styles for footnote marker */
..report .fn {
	white-space: nowrap;
}

/* styles for numeric types */
..report .num, .report .nump {
	text-align: right;
	white-space: nowrap;
}

..report .nump {
	padding-left: 2em;
}

..report .nump {
	padding: 0px 0.4em 0px 2em;
}

/* styles for text types */
..report .text {
	text-align: left;
	white-space: normal;
}

..report .text .big {
	margin-bottom: 1em;
	width: 17em;
}

..report .text .more {
	display: none;
}

..report .text .note {
	font-style: italic;
	font-weight: bold;
}

..report .text .small {
	width: 10em;
}

..report sup {
	font-style: italic;
}

..report .outerFootnotes {
	font-size: 1em;
}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>12
<FILENAME>FilingSummary.xml
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<XML>
<?xml version='1.0' encoding='utf-8'?>
<FilingSummary>
  <Version>3.22.2.2</Version>
  <ProcessingTime/>
  <ReportFormat>html</ReportFormat>
  <ContextCount>1</ContextCount>
  <ElementCount>23</ElementCount>
  <EntityCount>1</EntityCount>
  <FootnotesReported>false</FootnotesReported>
  <SegmentCount>0</SegmentCount>
  <ScenarioCount>0</ScenarioCount>
  <TuplesReported>false</TuplesReported>
  <UnitCount>0</UnitCount>
  <MyReports>
    <Report instance="cris-20221109.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R1.htm</HtmlFileName>
      <LongName>0000001 - Document - Cover Page</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.curis.com/role/CoverPage</Role>
      <ShortName>Cover Page</ShortName>
      <MenuCategory>Cover</MenuCategory>
      <Position>1</Position>
    </Report>
    <Report>
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <LongName>All Reports</LongName>
      <ReportType>Book</ReportType>
      <ShortName>All Reports</ShortName>
    </Report>
  </MyReports>
  <InputFiles>
    <File doctype="8-K" original="cris-20221109.htm">cris-20221109.htm</File>
    <File>a3q22earningspressrelease.htm</File>
    <File>cris-20221109.xsd</File>
    <File>cris-20221109_lab.xml</File>
    <File>cris-20221109_pre.xml</File>
  </InputFiles>
  <SupplementalFiles/>
  <BaseTaxonomies>
    <BaseTaxonomy items="23">http://xbrl.sec.gov/dei/2022</BaseTaxonomy>
  </BaseTaxonomies>
  <HasPresentationLinkbase>true</HasPresentationLinkbase>
  <HasCalculationLinkbase>false</HasCalculationLinkbase>
</FilingSummary>
</XML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>JSON
<SEQUENCE>14
<FILENAME>MetaLinks.json
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
{
 "instance": {
  "cris-20221109.htm": {
   "axisCustom": 0,
   "axisStandard": 0,
   "contextCount": 1,
   "dts": {
    "inline": {
     "local": [
      "cris-20221109.htm"
     ]
    },
    "labelLink": {
     "local": [
      "cris-20221109_lab.xml"
     ]
    },
    "presentationLink": {
     "local": [
      "cris-20221109_pre.xml"
     ]
    },
    "schema": {
     "local": [
      "cris-20221109.xsd"
     ],
     "remote": [
      "http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xl-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xlink-2003-12-31.xsd",
      "http://www.xbrl.org/2005/xbrldt-2005.xsd",
      "http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd",
      "http://www.xbrl.org/lrr/role/net-2009-12-16.xsd",
      "https://www.xbrl.org/dtr/type/2020-01-21/types.xsd",
      "https://xbrl.sec.gov/dei/2022/dei-2022.xsd"
     ]
    }
   },
   "elementCount": 24,
   "entityCount": 1,
   "hidden": {
    "http://xbrl.sec.gov/dei/2022": 2,
    "total": 2
   },
   "keyCustom": 0,
   "keyStandard": 23,
   "memberCustom": 0,
   "memberStandard": 0,
   "nsprefix": "cris",
   "nsuri": "http://www.curis.com/20221109",
   "report": {
    "R1": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "cris-20221109.htm",
      "contextRef": "i65fa79e006574b989ada023c81fde3ea_D20221109-20221109",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "dei:DocumentType",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "document",
     "isDefault": "true",
     "longName": "0000001 - Document - Cover Page",
     "role": "http://www.curis.com/role/CoverPage",
     "shortName": "Cover Page",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "cris-20221109.htm",
      "contextRef": "i65fa79e006574b989ada023c81fde3ea_D20221109-20221109",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "dei:DocumentType",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    }
   },
   "segmentCount": 0,
   "tag": {
    "dei_AmendmentFlag": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true when the XBRL content amends previously-filed or accepted submission.",
        "label": "Amendment Flag",
        "terseLabel": "Amendment Flag"
       }
      }
     },
     "localname": "AmendmentFlag",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.curis.com/role/CoverPage"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_CityAreaCode": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Area code of city",
        "label": "City Area Code",
        "terseLabel": "City Area Code"
       }
      }
     },
     "localname": "CityAreaCode",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.curis.com/role/CoverPage"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_CoverAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Cover page.",
        "label": "Cover [Abstract]"
       }
      }
     },
     "localname": "CoverAbstract",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "xbrltype": "stringItemType"
    },
    "dei_DocumentPeriodEndDate": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "For the EDGAR submission types of Form 8-K: the date of the report, the date of the earliest event reported; for the EDGAR submission types of Form N-1A: the filing date; for all other submission types: the end of the reporting or transition period.  The format of the date is YYYY-MM-DD.",
        "label": "Document Period End Date",
        "terseLabel": "Document Period End Date"
       }
      }
     },
     "localname": "DocumentPeriodEndDate",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.curis.com/role/CoverPage"
     ],
     "xbrltype": "dateItemType"
    },
    "dei_DocumentType": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'.",
        "label": "Document Type",
        "terseLabel": "Document Type"
       }
      }
     },
     "localname": "DocumentType",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.curis.com/role/CoverPage"
     ],
     "xbrltype": "submissionTypeItemType"
    },
    "dei_EntityAddressAddressLine1": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Address Line 1 such as Attn, Building Name, Street Name",
        "label": "Entity Address, Address Line One",
        "terseLabel": "Entity Address, Address Line One"
       }
      }
     },
     "localname": "EntityAddressAddressLine1",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.curis.com/role/CoverPage"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_EntityAddressAddressLine2": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Address Line 2 such as Street or Suite number",
        "label": "Entity Address, Address Line Two",
        "terseLabel": "Entity Address, Address Line Two"
       }
      }
     },
     "localname": "EntityAddressAddressLine2",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.curis.com/role/CoverPage"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_EntityAddressCityOrTown": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Name of the City or Town",
        "label": "Entity Address, City or Town",
        "terseLabel": "Entity Address, City or Town"
       }
      }
     },
     "localname": "EntityAddressCityOrTown",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.curis.com/role/CoverPage"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_EntityAddressPostalZipCode": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Code for the postal or zip code",
        "label": "Entity Address, Postal Zip Code",
        "terseLabel": "Entity Address, Postal Zip Code"
       }
      }
     },
     "localname": "EntityAddressPostalZipCode",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.curis.com/role/CoverPage"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_EntityAddressStateOrProvince": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Name of the state or province.",
        "label": "Entity Address, State or Province",
        "terseLabel": "Entity Address, State or Province"
       }
      }
     },
     "localname": "EntityAddressStateOrProvince",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.curis.com/role/CoverPage"
     ],
     "xbrltype": "stateOrProvinceItemType"
    },
    "dei_EntityCentralIndexKey": {
     "auth_ref": [
      "r1"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK.",
        "label": "Entity Central Index Key",
        "terseLabel": "Entity Central Index Key"
       }
      }
     },
     "localname": "EntityCentralIndexKey",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.curis.com/role/CoverPage"
     ],
     "xbrltype": "centralIndexKeyItemType"
    },
    "dei_EntityEmergingGrowthCompany": {
     "auth_ref": [
      "r1"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Indicate if registrant meets the emerging growth company criteria.",
        "label": "Entity Emerging Growth Company",
        "terseLabel": "Entity Emerging Growth Company"
       }
      }
     },
     "localname": "EntityEmergingGrowthCompany",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.curis.com/role/CoverPage"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_EntityFileNumber": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen.",
        "label": "Entity File Number",
        "terseLabel": "Entity File Number"
       }
      }
     },
     "localname": "EntityFileNumber",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.curis.com/role/CoverPage"
     ],
     "xbrltype": "fileNumberItemType"
    },
    "dei_EntityIncorporationStateCountryCode": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Two-character EDGAR code representing the state or country of incorporation.",
        "label": "Entity Incorporation, State or Country Code",
        "terseLabel": "Entity Incorporation, State or Country Code"
       }
      }
     },
     "localname": "EntityIncorporationStateCountryCode",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.curis.com/role/CoverPage"
     ],
     "xbrltype": "edgarStateCountryItemType"
    },
    "dei_EntityRegistrantName": {
     "auth_ref": [
      "r1"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC.",
        "label": "Entity Registrant Name",
        "terseLabel": "Entity Registrant Name"
       }
      }
     },
     "localname": "EntityRegistrantName",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.curis.com/role/CoverPage"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_EntityTaxIdentificationNumber": {
     "auth_ref": [
      "r1"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The Tax Identification Number (TIN), also known as an Employer Identification Number (EIN), is a unique 9-digit value assigned by the IRS.",
        "label": "Entity Tax Identification Number",
        "terseLabel": "Entity Tax Identification Number"
       }
      }
     },
     "localname": "EntityTaxIdentificationNumber",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.curis.com/role/CoverPage"
     ],
     "xbrltype": "employerIdItemType"
    },
    "dei_LocalPhoneNumber": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Local phone number for entity.",
        "label": "Local Phone Number",
        "terseLabel": "Local Phone Number"
       }
      }
     },
     "localname": "LocalPhoneNumber",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.curis.com/role/CoverPage"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_PreCommencementIssuerTenderOffer": {
     "auth_ref": [
      "r3"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act.",
        "label": "Pre-commencement Issuer Tender Offer",
        "terseLabel": "Pre-commencement Issuer Tender Offer"
       }
      }
     },
     "localname": "PreCommencementIssuerTenderOffer",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.curis.com/role/CoverPage"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_PreCommencementTenderOffer": {
     "auth_ref": [
      "r4"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act.",
        "label": "Pre-commencement Tender Offer",
        "terseLabel": "Pre-commencement Tender Offer"
       }
      }
     },
     "localname": "PreCommencementTenderOffer",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.curis.com/role/CoverPage"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_Security12bTitle": {
     "auth_ref": [
      "r0"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Title of a 12(b) registered security.",
        "label": "Title of 12(b) Security",
        "terseLabel": "Title of 12(b) Security"
       }
      }
     },
     "localname": "Security12bTitle",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.curis.com/role/CoverPage"
     ],
     "xbrltype": "securityTitleItemType"
    },
    "dei_SecurityExchangeName": {
     "auth_ref": [
      "r2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Name of the Exchange on which a security is registered.",
        "label": "Security Exchange Name",
        "terseLabel": "Security Exchange Name"
       }
      }
     },
     "localname": "SecurityExchangeName",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.curis.com/role/CoverPage"
     ],
     "xbrltype": "edgarExchangeCodeItemType"
    },
    "dei_SolicitingMaterial": {
     "auth_ref": [
      "r5"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as soliciting material pursuant to Rule 14a-12 under the Exchange Act.",
        "label": "Soliciting Material",
        "terseLabel": "Soliciting Material"
       }
      }
     },
     "localname": "SolicitingMaterial",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.curis.com/role/CoverPage"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_TradingSymbol": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Trading symbol of an instrument as listed on an exchange.",
        "label": "Trading Symbol",
        "terseLabel": "Trading Symbol"
       }
      }
     },
     "localname": "TradingSymbol",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.curis.com/role/CoverPage"
     ],
     "xbrltype": "tradingSymbolItemType"
    },
    "dei_WrittenCommunications": {
     "auth_ref": [
      "r6"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as written communications pursuant to Rule 425 under the Securities Act.",
        "label": "Written Communications",
        "terseLabel": "Written Communications"
       }
      }
     },
     "localname": "WrittenCommunications",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.curis.com/role/CoverPage"
     ],
     "xbrltype": "booleanItemType"
    }
   },
   "unitCount": 0
  }
 },
 "std_ref": {
  "r0": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "12",
   "Subsection": "b"
  },
  "r1": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "12",
   "Subsection": "b-2"
  },
  "r2": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "12",
   "Subsection": "d1-1"
  },
  "r3": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "13e",
   "Subsection": "4c"
  },
  "r4": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "14d",
   "Subsection": "2b"
  },
  "r5": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "14a",
   "Subsection": "12"
  },
  "r6": {
   "Name": "Securities Act",
   "Number": "230",
   "Publisher": "SEC",
   "Section": "425"
  }
 },
 "version": "2.1"
}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>ZIP
<SEQUENCE>15
<FILENAME>0001108205-22-000022-xbrl.zip
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
begin 644 0001108205-22-000022-xbrl.zip
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MO!IXSLX8TXNSIEF(I'*R3HZ/)H@,]]KIO2=Y-8&"GB)"RR?D>,#'F)\4KAD
M=L'@CTTGPHJ/>@ES-H$ML[&_<@^K=M901JF^->0_A[2VT'1DONH<B\+@8/ST
M@]%I'6\E<ZBP&SVE;R,(@_B\8E;"(9)61KO>RAAADEJ@\8S%R/7$]$MP3EO/
M*\!):)J=C&F?@D9+S#.QB?)F?0SO #XJ26Y?T7;94C]6OH'2-THP$FEZ:R\+
M@CF6P#(II!J$!P*D$NR1]/C!17<A6,;\IDS.$N/6, 4]QKSK P01(J($,<8'
M@ E@-#^@'AC+]SPN*PQ4GYHM](F<9]*O*<[39S#Z?,T*CS<6DXMYBU]%.G*3
M3@N'GLGQ-AJ^)?G[)@D$D1IGN9+<N=(^FV#T E#Y.F&J$I7.U7/6^!EFFZ!R
MMWZX&-]A(",\[ 6EDG06.<^%+1DN 0$<J,S FE$4B'X<43D/ $F&MG'B$&7/
M44K7P]B BAS ^2!>*+U"Y@<&@Q#$KC^&^9.W7=.+!Z85R;B(1@#,8G=E 4@:
M:W$$-ULST+2*3_ICH[6@ =QEBT*1$RK4P)14/K%=(%)(5>P'GLI<_>U3A>"P
M'>K'>=C,(FP3G#&+,>;$@I.LT,IYM4N)WKV"KH0UM2VMF[T-;SW)3< =U$GJ
MY92DJBY$PE5]1DIM+<Z>1GL&DRVBN&:X[HT%(ZV=UUS7U)BBE-0&JAGLR:13
M&JECUR*V=\D^&L48Q&C@VW6*T;LQ-WI?<GUKK6;,K(&]+G*O"\C*1!']$) R
M3  ,F'!'E!6B/#\/4W>!&A15-]$@!A^$IV[ZR!R[%)',<E_2<4#+^RZ'X'>:
M9+.D;S5!;BQH=[9/CI^D[ DE9F8AB+*8/\LN+TWVTO _8_$ X1S%D%17>@#Z
M2 J25 $N?^QU,S'2TEI1DNT?FO9$8UKO,!=24<XQE$K==?%"Y%M?F1]'8612
M635)K\H>M5"V_6!UJM#VLP# X9#*5JIW3E 9VC6!Z>#_-" 6)CQD[:33(LQU
MN:V+#=ZRVG":M>B?8A_BA0>,[M+2WEZE,%9FL9 \YF;;'*B-C#8ZF+.W.DQW
M\&NS=C]HU%<L0BL.0Q*,60WSLK%UJFU^UW3/G4\]B@H1#CIJ$ZB%N%9V>]N(
M!J/6[79KS=9A[;#9[65UP"^>0/-R&P'^0JQA&+66T:@UC4ZMW6@WY(/2WE/W
M+HJRAO(?1.A.<I "/D4H&6!,DAH[V4TGI/U=$O9L1X7DF4?>ASB!(^U5@\@%
M*1U,H(4R=?9*RN.Y-IA7TBHG?=#.^5TI;\ZEK[[P:?9MICI"A&^WXZ8.^ 75
M8K23$BIMDTIVEZ%B<ARS[ZN67TK0GL!S&!DGS(BMRJ'TUMS8\VN^ZL8CO3-*
MF_22RW5V(ITSV;Q$G?6Y.1(XL+&+?[.<F-K"9,98=MK[&)&%+LJ.ZSO<BK%/
M'6SLO8_A608)R->06U]'OI"[+7%S1]+S_.^+V[L3N1WJ[-+(O<Y.3VI&1\^\
MC+N+3\UY#S8;G<(&#!)-ZK?Y"HJ6<@BJ]U K=!KOP[NM7JO[KEYH6$14Q &H
M!M0AP'H\N/<)8"Z]$(7OXA:>J<8VVM.CX</%G23#9(N,L, *(>^C*< \>AAC
M8BYDGN_5?O/M>P >G#0G&1 Q(57=!V;A2HMORU(NLNQDFP4E][-."X+BP]T_
M,ZPPT0^ 0SW1S_ ]9W7%S;%3BYNS'PD'G;?_2-:\92$#7#7D-^!5CF4&=AV,
MAJ"6SX+XGIWQ$%=+2\CL0_T6HT-PXBF-C<_E4VN@D$G7)QV*,+=%97L5E&2Y
MTJ'OI-(\9[&J]41"ZOG,@Y@OMWJYP4/V/LJ6R\D60O!K\; "F*70/]C _L%@
M:C]0L<>P_VZR35[B^R_3$I&P,2Z",;(-0ZJ")]E8-5G2HBT!0&#'%SPZ$,3/
M$INI3G+-\42#?W'C4J%7/Z+&2!+VIJZ[]^S#Q1E"@IV@4JDE&[<2A4*Z[1Z<
M+\+13,UV 6KC"DP#<<:$;CV]J'5[O::F^-QRJ$T:EB1JI$SHGWC40E(<6T":
MT^UX\]@Z]!U@YRAVP=37LW60NR"+:_.4=%I%(X"E$ZF:1:FDQGX%ZS;2)& *
MXAF5-]H0@7$3#]!M%'\AY,6:^VSKHO8\4$,'\CLG3P<&\4"ER,2*BSZ2R (&
MC3V I8C2*#'G]JS2HHL&>C!8LXF6'7<V]B@0S$>$/WQJ[ST>_&'1OA5 V*H0
MOX)346?S$]AE#BW-F/8B!&,(@X -;OB]&9 !!^9YA'_6+GW_*_XF+YTB<+EK
M>:5":97*7S&5OR&NOAM2F1-#O63_+AH/4WCD[Q*#.(I!PI1!2#DF)I*;7FY;
M,9GTSZ#:,&2^Y2C)$79^7L)?]U*SWF!<Y[(3BU2<T>NUM<ROU&AL#%P<X8I(
MJ31TVB>F3]*^J+L374<=J^")H?? [W%:\KKZ?\CT,-PJR2X%1'UND^9J<+T2
M2^013;MU Z+O*/!Q"VM:2-<*F_ R5XQLL$1\TO6KNI%2ZZ<\)$FL2+BTU1";
M0SWIX*"ODAQ(D)8.LG;UPM9#&YU&"S.0-B49L@!E@F>"5/%%5)\$?E3,15MV
M00+H1^KE@5$/P;L-S0&/@$ <=U6:%OP+/"90*C(L2R%1_E@XXQ2 *<S,</+)
M3X>ETKV\&ZF>*17C(OX*.(/%/H&.U.4K$8\7%(8,FA(VE#LPZ(0E5(RHA=!Z
M:K+J 7%%GES9J0;% R-\3WJI\$R2K)Y@ [EQP^P+1TC_4VVTHF,YU+9[Y<7F
M=V2I#/CL<#4)%V=N?N(A3#XK-GEB_U,2!$]!ZCOJ#*& 8V:>],-3,=F"<502
MO<Z0@)D!U?Q-6U,F(Z?)$N++0H4J(&3J05": VAM6O)6>MX#Q*':4V8H/5""
MZ)X)@P *!5]Y$&I*+:8CH(L? MU'\C7I!H\3[:56B%E08B=P03_.M\E)X&<J
M#GCT SMD/_W0;!VK3=ZA1K_D-56FR5_*]&_ALE34N0N('<\N7 HY_UH<'IP<
M=W(D6NO$X %NHX\FKOE_3,(FMRX5+F'0GO\-""C<QBI2_H(U>4$6FHJ/R,"Y
M $U"R/Q%RB 6QI(^1P$"5T@%*2\!3X2@3!R3*J5*>8:4X0CY4\X6!H\@/NP^
M-@,@$9?QNBK8CGA H9^7'!+A/9!PXJ$Q(0:FP/7($A%EF?+,EB6DA(L;(F!H
M-J C:E3MCAC*).5NX1:WU";+K )2-Y"E85L,*!D?):D=G[)VR>D:_;%,CLU?
MHPQE^3?3'3D\VY:*$.#*0<OXY54XZOB?@,"-X&ZJP'.'.IBYWERI:Q"-A!9Z
M/\E+N'0V&9:VJ;9AVMCTRQ/4H]/E0/R2-T(#4SAQ0*Z//!L!/:)\VJ5P^DF"
M4BR3J%Y&  +K)8,82?G$42_IX 5W*VGY@54'=$R%H!FE #,QP,0#,$D]5;N3
M0V1L%GNY\TV^"4M(IL4%4G$.N,"3<@8PHS]&UE%Z:+2XQ$DKN%TY+S1!&2$!
M%@<6W!K2\1>2M?Z,!>5*\G3#DO@#^FUX< A AGF:*6<6^-=\\ /":"(EH!(]
MRD4%?!8L#+QH;-28\ Z34SOF($J1+N C1PD7S(!-'($:@/0)9IM,#Q_T_$QM
M2*F6[)[/=)G@R>4M6EJ90"C39!ZE2-/$HLI6"6"_& NM/'!#+7'63V].0'AI
MK*O3"TW.*]D;L]51OE:!VD8>E0.DR,K\<@-N4F;-5%5VRHK'D6DQKP&LD<$E
MWU%F'-6:.F-%'=$R';K,B4Y4]RZM2&&-%$YRZ%!!:+!L# HJ2 =F$TS"IX@I
M,X93Q, >WXSW8M"D*GY&XML<\8S)8I(&W-9+)XN!3( )S1*//Q>8/>G]SWEP
M^?SP7(C3O0) CEGI1[;_X?04:R_)<PE_SI%3])<]J0@?%!QX!)GL$4DT9IXP
M,"\@5G61RK-VR+>B!R.L+   =6I@D2>;(8XEIOJI\J+M+ZB" @2&6H8"G#J!
MFI+<DYLGR.%-I$)>NNZ#9T;'[9@C[+Q+\N%@,7&[%5I;V4Y%$::O4KE@=P:H
M95#</2MV^P$I5ZP;2K.<-ES1R53RW[6D+2MMPB)^3&@SO6M+FRC+T8%Q\J@(
M)4JXZ4(FE $O Q/T$QKE@D@^@OETQC7_$8.5,.Z'PA84]\BGY%9R!PT[E@P#
MCM!CG$ZGF\SH('MJ0<5!^TKUJH8OT&T@X61UI=>P^+AD:[ +SE+*CFK +C;D
M@U^1J('TZ8EZE?3.)X(=*N3*,JX"Q R B/<YI[N?5BAI#(?R$K(6(!<X-!_P
M#+#$84J-.I@KC!Q\KW! HY93?,"8,L)4@0.V7-'R$G>!=)'"'E$-W3@Y1QJ:
M6I)C)8V\XFF0P/YHV!%1*+J)2^#WB3ESTHMO4GI.1&FUC(XFLU-EI*GST9#I
M0!^.J*:E FA4!;[+L].NYFQD2'R5/$LG5)Z58O*GMMUI6>2%FAD!2^2"O!1J
M)H-HC,I3I.!'M"<I/<A+WI4I32V)P\B:J Q8IL6U ID56=&)DH0M'+L);X>R
M,6X&EZ4*.6MID]SXF&<@C]_+M@1PV,V,<>:QR\0<(%5AS(M 99G2>D&?Y3G)
MDOI56B?Y4#)ZT8SCJYG^ :1E(7#"\;9J8T#!L7G2,(ZN?M[$SS* FFH15$ED
MBD;H_)N^#[ZTPM8H[CO*3B2WJTK%CE0J^KZ=8]/$UU"*BGQZY3IFCJ':)PF2
M%RGK+GT]:72P=3D)E\F-EAH$Y2M)"-9H.Y<KHTVUYS(M8\AH&RB5]*'!/!;$
M"/ T@/D%/"#2IDK9D L P_FNL#(YQ3WF)E@53""*T PC2A))-F9##D8.E MN
MXB6UAI.C_I-7<B)#^BND9EQ,6^9B"%0L@>^H16,+AL 0B:KI,&,0CZ2:RK72
M*B<^?V6@6O<3#QC])%)\DA@V'V$^*(?=3!4J597 D^GK)$R:H:D"$W>W*[,U
M(S5P>OWOB[.:T0-X/#Q+QR)VD /*T,\/XX!G@*LMM*"@< ZI321<Q=3J5# 6
M),]-^5RHNPJ5_H*[76?4N$(G&E)J4*)K/O 3:$H5- PXC3(19GF=I/G^V1P.
M^?>>W,5(5G BJ=/G.,5229TG<E;J$& 9QRF 0FESHV$^^#%5-HIR9#=H.#[2
MX^PV=D%TQC)WADPR^40H;ZF#*UWL  [D"7P?L;QHZ+5_TGO)KW]EW5$%%-%9
MGK+O5^H!*5,#8!609/G,8[+; +D#<.-BEB?-"^?*G#C#^3?P7L%#Q,A$I0#9
M/@%[>WY*?[^;:*V1/8D2F6_;\(V:=0;YTBWIM#XTI%EF J3?H?.D4+KD6?+H
MF\JF_30_X0C\!,M(GH"1#I=/O\M1Y3B4K >? QQ9G!2=JT33(VD<4U#Z2FX]
M\2)U0(L/:E(I8^#GM$T[GSB?FU.E(_0HR84O)3V4Q4KXXY 3*U!53JD7>!([
MQPH--RHP2+1P(#GH46#]D'^S..A8,PT5TE '!,@Q'W?H@-(M]6LV_(&'>=T[
MM/;3+S<7MQJ[N#I=B$_>%D)YT,;UU=GYU>WY&1BVJ]OKRXNSDSOX<7L'?WTZ
MO[J[9=<?V?7G\YN3NPMXX/6^,;&!M>]_N3KY<G8!ZYT^%+4D$%Y@_L>/80R,
MD90RDN='4<"4GB:%]>OE5S&OOTVZOJEN"<#<URA8'(7\*/G',:AV/)OP2'@$
M.;VTTO>F=+VN2UT1 3B1G<RL;M?IUD%D3]]KP\UV>^YMO6[,O??4L(9>;_9:
M*PW[]+VVT=T>8)N=U4;=+6 ["PU[0)PKN1<$)(3HX!][S?2+;.JPQJ/&Z!LS
MDB,KI3S@^8V3,B+%8SVJION<$ZGKZ4$4J2I0RTU7TEMD)>JK4:^XE@7-[MTP
MX)Q]\FFG\CGN5$8]5]B+.W>ETS33<9U[6X^4*RP\+8Z3'6?HA592&MH5/F[W
M H[=NE4;W^6J*UH_JW^FL]B6Q?E@<+RD8HK\T5MMS=:GSD MGN4XGX!S%ZM<
M<UC$D8&! 6V42D!?@D.>Q>9+QJB W!R02TN1J@5-2!&COWLE%"?J)!"YH^2+
MCOI""]39!KR8!1?XXXL6=CR9<"O!BAI:M]6<[9VMPI5+K'$ID9N8<E)L*_XJ
M*W\U-;W=K?BKXJ]76E%':W8Z%7]5_/5J_-7N;= ^KBGN*JW'>*V:U"@,FQM[
M-99;\$P)*0M#T5=6&\=+LM039'TME;5HI%01IR).19SOG3C&YLBRZUF54Q^_
M\)X824I5KF0I%_4ER\)2^T;WW1;[]#M*DUY%D]+11&]41"D;4;KZ1FBRSH"Q
MV2F?,;RCKQH$^;K=2\+&A6HXI6>VAM9MM%=SP!9&P!8YS;M!U*:F-WL547>+
MJ!VMT:DD=>>(VC9:)27JFH+CLKD!^"%,=?"+VJF^>O>.6O'K]9PLZO]60)8:
MR%VOQ<S[N.QW498Y;%1YY3+2Q6AO,+-<$>8)PG0/*\*4D3#-S@8)L^NUF'G?
MC/XN"C*&KG6-[6\6W4G:=+5#?5D7IB+-VRCDEM;N+.O%5+1YF\QY2S.,#<K-
MKL>4\S]6_EU$E2#Y[<I-+BEIFLT5D[85:5X[YM>:QK*;1BK:O UM&EJ[L4&Y
M66> 6=[^!FNJO/&2 '-NJGN+V*ZMM9HK^M"++7^+O.O=J)H:34WOKKAUJS2U
M\(JJ$U1MZYJ^=(=#1=624[79T?15P^3RM3AL6<OCI1^&\M3@[!3I5^EYW!Y^
MW <W]% _7+S#=JFE;U'<L!OJ9=\ J]%:8K='U1)7=HJV&EI77Z(%OJ)HV2G:
MZ&FM7@EE=$<['.7.>!7^5\V-%9"O"^0S4I0<+NWY'G\:INK)XI.[7N&[P",K
M>8A??,%O 'T79;UF<\4]'%OJP6P-8=I51:^<=%GZC*Z*,&]45]E@G777FT4O
MW%$L/RJM3*3RYM-O<*HOV^+GT'(?H0_FG:*Z3-YY:SAPW]#T1K,ZOZ"$9&EW
M*K*4C2Q-S6ALYF2)BBQ/DJ5YN$0YXNTZ2,L7$&_+D^L,W!O=\GDGZDNG%+6S
M?>6:O'OQB2I;([/5<8(5<2KB5,39,>)T>_IN1/1E;,61W;E^OC3WG3?F[A]V
MES^ELQQM.&_1Y;=%A(2 7U\^#U.1LH2D;&CM5D7*'2%E<X5CD%^7E+O><'O%
M(^;XX>)?,7MY8^W6?;]EN2674K2,IM;HM7:SA[ABU=UB5:S&&!6K5JQ:>E9M
MM;7F,LYGQ:H5JVZJ:&=H7:-LFXAVM)T]\:G9B >P+M?U/18.S8"S_;X9"DL>
MJ"8<;)AY2;C3!+3;?MQW^.);++9.]I9?=BGE3Z\;2[C?2R]ZPYF*BFEWE6F7
M_]I.Q;05TVZ6:5O+?[>K8MJ*:3?+M,UV"9EV3=GOLCGHO],/;C,3 #'O><%)
M#Q?QTI=IIU!DDIB=I-1+!;8L'-QK:IV>H1F=%?=8K M)6]1F\WWPA:$=ZH;6
M7/6;$Q5?["A?-+1F1]>:[9=]]JWBBUWC"T-KMQM:J[GLV?LEX0ORF XB$\:%
MOVWQ\/X7^D.NHH\WU8(6N9<L5Z&HTP <COQ0X+E81[2S3CSPXT=A1T.%O_Q;
M"@EZ]HK9#WUT:*9>F0M$_L]AD(P\ J>IU@^X^;5F#B(>')G.HSD.B].[PJOE
M 9\'YB2"]YX!9O:K%L>=A_/???%;KAG<PXH44MM%\2F,\T))Z3TG* W9F(SB
M,?WGTJM>MUQW9H)[^N7FXE9C%U>G];)">'UU=GYU>W[&X%^WUY<79R=W\./#
MR>7)U>DYN_WM_/SN=LT\M=D5[W^Y.OER=@&K?%=6""\\%@W]&,:PP^6!7)=
MSU/<I.8S;4NV!1#BF*.0'R7_.$XV7 F/%D@O'4]//AD3(RSR=J8YZ[K4GBHD
M5S.KVW6Z-6$HY;UVH]YJM.?>UNO&2O>,>K?;7/NHC?IAM[4B//-18/3JG>;Z
M@=7KO<:J;SYU#X*FM:.@4^\8ZT?LZJ,^A]?%&+;:%+KQ)Y\AP1*G?#W[:"^+
MDPJ>_K/G[4TK]TF-ZPK;=OBZ[1N-<R0BF,-ZVN*1:K_EHXB[?1ZPIJZQAMYH
M+' 4WG>/M3-N*:09A#2C@+0%V;-PQ$I=;VPR;SU[F2>WMWD?=)T,\>(S_EYU
MRC>J0Z2A_%POT:BCJZ:N41JAWL$K:J(:CGIDI#O@A6>#T!S5\,J;I5'0-)Z:
MX5!C%OS)^)^Q># =@$-^94-X#SR,\$..X41T_1IYK55/_]NP_"U8EEP3+\[,
M*[WUXGI=[; [)QN[*9:HV&KKV<IH]K1N:TY5\,4\L=9CU4K)'#>@K -A8;4:
MU?E+#D9^5JH.7]1Z6PIV.YQW7.E:$54AFY#=:<SYX..+$;76DX1+*=<GE@7P
M@T\60.P"#EK?F7^\PCHLYE/LMB6FI*%UNR]AN+=T4'8 W4VM,>_KAY7=?A9[
MGP/\@E$TEE\VA!ALA"'7TT>.569%FI7NG&-]*AO^&A^Q>RV':?=M^+7\1IEW
MSQQNXEG'>*_F#VHQ_###<$51_XYL3$OKS/OZ\?=@TC=Q/+W6:;U6EF?WK?JO
MOF\_"L>I3/@S)_-IO>Z<CM_*B&\7NG??C'\.^,@4V??'R667!Q^2$9__<8*2
MFI4W3[IIQN%K18H5NF<%YH=SOC%3*A/>J7=*>.*9/-?T!8*]1MNT] <CRZE
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M5?GV_FD#\[5!L"*#8=(/TPX\P*0IV@F],$.V72:2E'([$\1+KF\_EM'5V2F
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M   1    8W)I<RTR,#(R,3$P.2YX<V3-5<ENVS 0O?LK6)U+;8X7";$#-$&
M NZ"-$%R*RAJ)!.12)6D8N?O2](2'#EQ4P,]U!>3,^_-/M3YQ;:NT!-(Q01?
M>)$?>@@X%3GCY<*[N[W&<^]B.1J=?\#XX=/-"ET)VM; -;J40#3D:,/T&MWG
MH!Y1(46-[H5\9$\$XZ4C78KF6;)RK5$<QO&A5J8PC\@9C2,\CO,<GX5S@K.)
MN<YH1)-I.*&3;/ZQ3"<4BFD\RS!,0XK/BND,D_%\CFD29T660)A!X8QN5:KH
M&FJ"3&)<I5NU\-9:-VD0;#8;?S/VA2R#. RCX.'+ZH>#>AVV8OQQ@-YFLNKQ
MX\"J,Z*@AU/)AL9I:R0^%75@<XVB,/$0T5JRK-5P+61]!05I*[WP6OZK)14K
M&.2FWA78B@X +]2:R!+T5U*#:@B%]SPN1PC9*K"Z$5(C_B:O*T.4)$FPM7EY
M:%>UE:!$NU$X6@:'Q_:(HQB/(W^K<B_X*[=#0XPK33B%4WR;&^YY_R*&?4]/
MBZ'GG1Z#,Z: ^J5X"G)@KG-ONU?'X/: [6'HDW NM.-;22=K&L8+L1,8D0T\
M[:._@:)?DU>S_\:(N+^42"I%]<X\!8T4#4C-0+W<&V=@+:%8>'9[<#^U/RN2
M^2:2'O+*P; %5AT8"E2K?28]5S\WAJM, RK8U>9_3KR1<&KBAJ+,>^$:?6+^
MEG]K](CE"^]2F'?_.RE-?%9^=_/YR-OBO.[1O<G>: X%X\R-7>A^$<+[[P1&
MCHDL]3PX)!R8:A7DW_C2G0_3[,@=Y ]$2BK:5J?S]F$=I77"OHS=F@7#/=O=
M7^RB$^P6?#GZ#5!+ P04    " !#@&E5ZPH ?HH*   180  %0   &-R:7,M
M,C R,C$Q,#E?;&%B+GAM;-5<:V_;.!;]WE^AS7[9!<I:I*@'BS:#;J8=%)MI
MBR9%![M8&'PI$<:6 EEIDG^_I&PG5DS9(F6KFB^)']3EN4<\EU>7I-_\<C^?
M>3]DN<B*_.T)?.6?>#+GA<CRJ[<GWRX_@.3DE],7+][\#8 __O7UW/NUX+=S
MF5?>62EI)85WEU77WG<A%W]Z:5G,O>]%^6?V@P)P6E]T5MP\E-G5=>4A'Z'G
MWY:O90(IY@B"  D!L)]0P$+U-N:0D\@/><B2EU>O0R[3",4,R,CG *=1#&B0
M)( 3Q%)&I,]D6AN=9?F?K_4?1A?24\[EB_KMVY/KJKIY/9G<W=V]NF?E[%51
M7DV0[P>3=>N35?/[K?9W0=T:$D(F];>/31>9J:$R"R=__'Y^P:_EG((L7U0T
MY[J#1?9Z47]X7G!:U9SOQ>6UMM#OP+H9T!\!B$  7]TOQ,GI"\];TE$6,_E5
MII[^_^WKQ]8NR42WF.3R2M_9+[+,"G%1T;(ZITS.%/K:6O5P(]^>+++YS4RN
M/[LN96HV.RO+AE6-DFB4,-(H_][6V:0'_ /AK;:Q'@!<[>ZG0V'<Q>FG@\&]
M5/%!'A_P1C>](2\'U/M<##5V'[OJ#?WXB \U+(J*S@88%D_=;$">Z0_.U:M5
M-]K0CF!:][,*W1M0Y7TE<R&7T;)AVLO$VQ/U:BID-GV?5UGU<*;FO9+./JH+
M[O\M'Z8X)) S1@&GE  <,@1H@BB@:O)",:))&B?3ZG%03V4.OEVL^Z\[V=/#
MB85O58M&2[DH;DO^-+O-9Z8I2\U6>GY+)CF=R\4-75V@8.I$8(G\= G26Z'T
M:IB>POEF\N22"Y&SX],S&QDS!6]@F>ETH"B?>U_P_=X_Z6NA@->N+R1_=57\
MF*AK)SKMTB^ ?E'+JMWB9.OFO2O7.&G)]_"\:C'AA<IU;BK0H%SGAAT=JHJ.
M]WU)G>KVQ"M*(4N5OQI<,(R_=T*HF[]8_5-!1*(I%C@4+(4 ,QP!3(@$280P
MB%'(*(I#1@)F)V9#+R,5] KBR_4+3X/U+N\*6V&;B.TJ[IYT#2-P>Z8<A+Z#
MB1YB-UD=6/ ['-L6_:[&KL*_I/<?A0HF69HM'[\^W<Z9+*>Q%#%6-QZ@@*@(
M@!@#C$H$D(S"2'*9"#^V$W]+3R,-  JMUX3K+?':!H V@KL&@0/0-DP@L&?,
M(1#L8:-',&BS/'! V./@=E#8=\'A,@(X#7D4AU&@@D*B:TXQ@X"F"($@2D3D
M8QP+'/7-".!( X)YGON<R_X9 >R1$5C1]3,S@EU,'20C@$?)"$QJ&3@C@#89
M >PA_,N2ZBKWQ<.<%6HT1B02., @2I%0Z3\5@$D_!CR5!"4R)3+VNXJ]87EL
M E^!\Y;HNLNY2==^"3N3<&39=O3?2J1&7YV$V;0TF!B-#FP*T-S =;;]D,WD
M*C$,:<H((A0D<<P %@0#BI0"110G2$@"$45VD^R3\;%);S5C:(".Z?4&<5TG
M43<ZAID[NS#A,%MNN]QCDMPP-O#<N.W&]I1H:&,ORB^E/"OF<ZEPZ:7=CXO%
MK2PO=5V\_)RF:JPA2 F)@P1P'Q& )96 ^ D',/ 1980F#(==1;JOL[&)5N$%
M? .PMT3L+2%[->;N,MY+]7Y9'Y+ (\N\%W=6PN]*BE,@V&M\L,#0U<W-0-'Y
M&OO <5',,IY5*C'XG2HM9G0VC440I0%E@//85P_-*0(L(A"$(J$P#8)4!IU#
MQ;;YL06')X3>&F+W6&!@;[_Z^W%R9+W;T&$E[W:OG01M,#>8A-M=V13MCE8]
M2UQGZN7G\K*XRZ>,X( QA "".%9:5<^\E/DI8!B'7(F8^I@X%;B>^AB;8)\7
M;312Q:.GL3J6MC8(M2QLN=$T<%FK$T/N):UM#OH7M#9L_IQRUK93K<4L0U-7
M@7_,>5'>%&5=%[^H5-PX*V[SJGPX*X2<TBCDTA<,Q!"JB3EB 6#,YR#R,0T0
M3Y 4PD[L._L;J? ;F%]Z-6H]NE?(/0W=-@[LYKUK3#@8F\/$AUY$.H2+3O3T
M"!V[[0\<1CHYNQU2NEUF'U[T7N79E^LB7]>>F!^I)_Z(@4#%$8"Q$( )YH.(
M,"Z@GPJ$9==8\MSXV )'C<^K 5H7[;:(VQ\,^M!Q9.5;,&$E\#:7G=2\96PP
MZ;:YL:G3UC8]D_HOQ:*BL_]D-\NIGA,,$TE!FH9JJD]H")) <"!"]5Y&<11*
MZI37-[H9FU"?)ZY+L)Y"ZS2K&YFU3/"=^1HXQ^]*E7N:;V2B?Z;?-/MSDGVC
M:ZWYOKFUO?R_EUE5R5Q7]F[SU5Z8Q11%04A9)('/X@A@%$ U,6,*:)HF(O %
MH;#S/C9C#V,3_0JDUT397>MF&O?+O#<Y1U:X)2]6PM[INY.FS18'D_-.AS:5
MO+NAO8CUP_^[4M+5 [I@J= [3R4/ (:!2JI#E5DCAF(9T 3'2><=*)N&QR;9
MNJ"DP5E.RPVR]BO4E8(C"[.C]U:"-+GJI,.&H<'D9X*_J3KC]PYB*W[(\AU;
M5"7E59<!M-E^3"-(X_+^NT;VOP.-(9.W;H.H86FX461RH#&,C T<%CTEOU7S
MP -$[#*K9G(:<.[C$"4@AOKXD!]*E6\)#+B*Z(@EJ93=3PX]-SZVX%V#\HK4
M@^@?[)_>&J[%HN=S]O8+L0\G1]:B+1UVBYXM?KLM>3XW-MR"9XL;C>7.MC;V
M\ES_0,6ENG0:(N9+$F$@4H( QGX*:*(2*T%%@!B3+/9A5VEN&AZ;+!]_E4.#
MZR[&!E?[A>C*P)%%V,UY*^F9/'627</08)(SP=^4F_%[>ZF]4S:$MO-A1J^F
MA 0L\%$,J"]3@%&,@9H E?2B ")(6$1AYZICP_+8Q/8(SM/HNJNM2==^N3F3
M<&2]=?3?2G!&7YT4U[0TF.2,#FQJSMS /?U\?\^OU5V1G]2=FL98D(@3JG?D
M2H#C* 6)% RD.!0^D8S$:><%.5,'8Y/@&J.W!NEIE/99:(/$[IFH*S5'%J8E
M*T[)J,GU7@EIP^#@2:G)'5-B:FSGNFCW55YE^C$TK^IQQ[! ?L0$B"@C '/,
M  DI!F$<$HAQ0&1JN0VOV<'8Q+M:?7H":2E>(XG[Q=N7FB.+UY(5AZ4XL^L]
M%N&>&1QX^<WLSO;"6TL[5_&^G\OR*LNO?BN+N^KZK)C?T/QA*GR:PD#X(,$I
M!3B)0T!X'(-(,BPADU!2RQ^0,/8S4BFOL7I+L-X*K:VDS=1V579OPH81N"U7
M#D+?R40/O9OM#BS[G<YMJW]W\Y[;;NH]=I_++V7Q(U/PIX' )$0J"L1Q&  <
M<A\PI!Z!$:01]V,_2+#E#\*9.QII&'C<3_*X&W0-V''SS7-^NX:"_JP-$PL<
M"'/?@M/"1O]-.,\-_YQM."WNM6[$:6OO7G%^_!W07Y7E*8E"A"7E0$8I5K&
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MUSDW).N6X>A&O<,$MO=;R,!XQB@1>61$AI@1FV>8*!FGE(C2638NO?C6VC
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M=NY.='^Z?Y<XV/DO4$L! A0#%     @ 0X!I59T$M"?W)   S%X! !T
M         ( !     &$S<3(R96%R;FEN9W-P<F5S<W)E;&5A<V4N:'1M4$L!
M A0#%     @ 0X!I5570^O3C%   H98  !$              ( !,B4  &-R
M:7,M,C R,C$Q,#DN:'1M4$L! A0#%     @ 0X!I56=&IWEI @  <@<  !$
M             ( !1#H  &-R:7,M,C R,C$Q,#DN>'-D4$L! A0#%     @
M0X!I5>L* 'Z*"@  $6$  !4              ( !W#P  &-R:7,M,C R,C$Q
M,#E?;&%B+GAM;%!+ 0(4 Q0    ( $. :54(K,TMTP8  /PR   5
M      "  9E'  !C<FES+3(P,C(Q,3 Y7W!R92YX;6Q02P4&      4 !0!/
) 0  GTX

end
</TEXT>
</DOCUMENT>
</SEC-DOCUMENT>
